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Abstract
Metabolic fluxes in cells are governed by physical, biochemical, physiological, and economic principles.
Cells may show ”economical” behaviour, trading metabolic performance against the costly side-effects of
high enzyme or metabolite concentrations. Some constraint-based flux prediction methods score fluxes by
heuristic flux costs as proxies of enzyme investments. However, linear cost functions ignore enzyme kinetics
and the tight coupling between fluxes, metabolite levels and enzyme levels. To derive more realistic cost
functions, I define an apparent ”enzymatic flux cost” as the minimal enzyme cost at which the fluxes can
be realised in a given kinetic model, and a ”kinetic flux cost”, which includes metabolite cost. I discuss the
mathematical properties of such flux cost functions, their usage for flux prediction, and their importance for
cells’ metabolic strategies. The enzymatic flux cost scales linearly with the fluxes and is a concave function on
the flux polytope. The costs of two flows are usually not additive, due to an additional ”compromise cost”.
Between flux polytopes, where fluxes change their directions, the enzymatic cost shows a jump. With strictly
concave flux cost functions, cells can reduce their enzymatic cost by running different fluxes in different
cell compartments or at different moments in time. The enzymactic flux cost can be translated into an
approximated cell growth rate, a convex function on the flux polytope. Growth-maximising metabolic states
can be predicted by Flux Cost Minimisation (FCM), a variant of FBA based on general flux cost functions. The
solutions are flux distributions in corners of the flux polytope, i.e. typically elementary flux modes. Enzymatic
flux costs can be linearly or nonlinearly approximated, providing model parameters for linear FBA based on
kinetic parameters and extracellular concentrations, and justified by a kinetic model.
Keywords: Flux balance analysis, enzyme cost, metabolite cost, concave function, elementary flux mode.
Abbreviations: CM: common modular rate law
1 Introduction
The metabolic state of cells, defined by enzyme activities, metabolite levels, and metabolic fluxes, is constantly
adapted to the cells’ external conditions and internal demands. Since the main task of metabolism is substance
conversion, metabolic fluxes can be seen as target variables to be optimised. What metabolic pathways should a
cell use in a given situation? How should fluxes be adapted to external conditions and perturbations such as gene
knock-outs (e.g. when should a pathway be switched on or off, by changing the enzyme levels)? And how (through
what enzyme and metabolite profiles) should these fluxes be realised? To answer such questions, we first need to
see what fluxes are physically possible. In flux balance analysis (FBA), a set of possible stationary flux distributions
(or “metabolic flows”, as I call them here) is defined by flux bounds, the assumption of stationary fluxes (i.e. mass-
balanced internal metabolites), and thermodynamic laws. Geometrically, each flow can be presented as a point in
flux space. The pattern of active reactions and flux directions in a network is called a flow pattern, and for each
such flow pattern, the flows with this pattern form a convex polytope in flux space.
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Figure 1: Enzymatic flux cost and the choice of a metabolic flow. The enzymatic flux cost of a given flow is defined
as the minimum enzyme cost at which this flow can be realised in a given kinetic model. (a) Flows in central
metabolism. Two basic flows (fermentation and respiration) and a convex combination (respiro-fermentation) are
shown. We use ATP production (circles) as a benefit function and normalise all flows to a fixed benefit value
(i.e. ATP production rate). (b) Flows as points in flux space (projection on the plane of v1 and v2). The set
of feasible flows with a given flo pattern (i.e, given flux directions) is a convex polytope PS (called signed flux
polytope). At the same time, each flow pattern also defines a set of feasible metabolite profiles, which form a
convex polytope in log-metabolite space (called M-polytope). Given a desired flow, each metabolite profile will
require a particular enzyme profile with a particular cost. These enzymatic costs, for a given flow v, form an
effective metabolite cost function on the M-polytope. Minimising this function yields optimal metabolite and
enzyme profiles and an optimal cost value, the enzymatic flux cost. (c) Enzymatic flux cost as a function on the
flux polytope. The flows that realise the desired ATP production rate lie on a diagonal line (called B-polytope).
The flow with the smallest cost on the B-polytope is assumed to be optimal. In the example, the respiration rate
is limited by a flux bound (dashed line), and respiro-fermentation turns out to be the optimal strategy.
But which flows will actually be realised by cells, and how do these choices depend on enzyme kinetics and
environmental conditions? Flux prediction can be based on mechanistic or on functional assumptions. In kinetic
models, metabolic fluxes are explained by enzymatic rate laws and by enzyme and metabolite levels, and a
metabolic flow can be computed by dynamical simulation. However, even if the rate laws were precisely, these
predictions would still be uncertain because they depend on enzyme activities, which are variable and hard to
predict from mechanistic models. This problem can be avoided by “economic” models: in such models, we
assume that any physically feasible flow can be realised biochemically, and we ask which flows are most profitable,
e.g. providing the best compromise between a benefit (e.g. biomass production rate) and a cost (e.g. enzyme
burden).
Minimising cost at a fixed benefit is a common approach in microeconomics and is also used by constraint-based
models (CBM) to predict metabolic fluxes. Constraint-based modelling approaches such as Flux Balance Analysis
[1] or Resource Balance Analysis [2] constrain fluxes by a stationarity assumption and other, typically linear
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constraints, but they do not consider enzyme kinetics. Since cost functions and flux constraints are only loosely
inspired by kinetics, these methods lead to less good flux predictions [3]. Classical FBA predicts metabolic flows
by assuming a linear benefit function b = b′v · v (e.g. biomass production rate) and maximising the benefit b on
the flux polytope. Classical FBA does not suppress flux cycles, even thermodynamically infeasible ones. This leads
to underdetermined, possibly unrealistic solutions. To fix this problem, one may penalise fluxes by a cost function,
and there are different ways to implement this. FBA with molecular crowding [4] puts a bound on a weighted
sum of all fluxes, assuming that each flow entails some total enzyme concentration, and that this concentration
needs to be bounded to account for the limited space in a cell or on membranes. A linear relationship between
fluxes and enzyme levels is used as an approximation. Minimal-flux FBA [5] works similarly: here, one predefines
a flux benefit (b =
∑
l b
′
vl
vl) and minimises a sum a =
∑
l |vl| or a weighted sum a =
∑
l a
′
vl
|vl| of fluxes with
cost weights a′vl (where flux signs are ignored). This procedure favours sparse flows; many reaction fluxes will
vanish, and specific pathways will be selected.
To justify these methods, one may claim that a bigger flux requires a proportional increase of enzyme levels.
However, in reality, stationary fluxes are not proportional to enzyme levels. A proportionality would only hold
if the metabolite levels were fixed – which is usually not the case when enzyme levels are varied. This is why
linear cost functions are not very realistic, and this is also the problem I address in this paper: in reality, different
flux modes in cells require different metabolite levels, and this results in nonlinear relationships between fluxes
and enzyme demand. To compute the enzyme cost of a metabolic flow, I combine kinetic and constraint-based
models: I use a kinetic model and assume that fluxes must be kinetically realised (i.e. by metabolite and enzyme
levels) in such a way that their overall cost is minimised. The calculations are based on a principle of minimial
protein cost [6, 7] as implemented in enzyme cost minimisation (ECM) [8]. ECM determines flux-specific enzyme
investments by a convex (and therefore computationally tractable) optimality problem. An optimisation over
all possible metabolite profiles (see Box 1) yields nonlinear flux cost functions, which represent realistic enzyme
and metabolite costs and can be used for constraint-based modelling. Below, I show under what conditions such
functions are strictly convex; Using such flux cost functions, I propose flux cost minimisation (FCM), a generalised
version of minimal-flux FBA that accounts for quantitative enzyme and metabolite costs in cells, and that leads
to concave optimality problems [9, 10].
Flux cost minimisation resembles some other optimality problems that have been studied before (e.g. maximising
a linear flux benefit at a limited sum of enzyme levels) [9, 11]. For these problems, it has been shown that the
enzyme cost per flux is a concave function in flux space, and it has been claimed that optimal flows must be
elementary flux modes (EFMs), no matter what underlying kinetic model is assumed. Here I extend these results:
I show that the enzyme demand per flux benefit is not only concave, but often strictly concave, and I clarify the
mathematical conditions for this. As a consequence, optimal flows must be vertices of the flux polytope (while
for non-strict convexity, which always holds, there can be additional optimal flows that are non-vertex points).
Optimal flows need not be EFMs, but can also be other vertices caused by flux bounds. Below, I illustrate
this with the simple example of a branch point model that describes, in a simplified way, the choice between
fermentation and respiration. Of course, all methods also apply to complex networks. The relation to cell growth
rate, “bacterial growth laws” [12], and cell growth maximisation in whole-cell models is also discussed.
2 Enzymatic flux cost functions
2.1 Flux cost defined by optimised enzyme and metabolite cost
To realise a metabolic flow v, a cell must provide suitable enzyme and metabolite levels. Typically, higher levels
are costly: increased enzyme levels, for example, have been shown to impair cell growth [13, 14], and such growth
defects, as “costs” will also arise when fluxes require such higher enzyme levels. In flux analysis, enyzme costs
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Box 1: Screening all states of a kinetic metabolic model and finding optimal metabiolic flows
Set of all metabolic flows In a kinetic model, each metabolic steady state is characterised by a choice of enzyme
levels and the resulting stationary metabolite levels and fluxes. The set of all such states (enzyme profile e,
metabolite profile c, flow v) can be parametrised by choosing a flow pattern, a flow and a metabolite profile that
agree with the flow pattern, and the required enzyme levels.
Orthants can be excluded by thermodynamics,
or because the stationary plane does not
intersect the orthant.
Excluded
Excluded
Constraints
Upper and lower bounds
Positive thermod. forces
Constraints:
Stationarity flux bounds,
fixed or constrained
benefit
Each orthant
yields
Find all feasible orthants in flux space Flux polytope
Metabolite polytope
Screening the metabolic states The set of metabolic states
can be screened systematically (see graphics). First, we screen
all feasible flow patterns and construct the corresponding
S-polytopes and M-polytopes. Flow patterns can be excluded
for thermodynamic reasons or because they corresponding
orthants in flux space are not intersected by the hyperplane of
stationary flows. Then, for each flow pattern, we screen each
of the polytopes, and consider all possible combinations of flux
profiles v and metabolite profiles c. For each combination,
we can easily compute the required enzyme profile e. This
screening yields all possible steady states (v, c, e). To select
only stable steady states, the metabolic states need to be
checked by inspecting their Jacobian matrices. The screening
procedure allows us to parametrise all metabolitic states of a
kinetic model, and it also shows that the feasible S-polytopes,
as a set, represent all feasible steady states of the model,
projected to flux space.
Computing the enzymatic cost of a flow We have seen that the metabolic states of a kinetic model can be
systematically enumerated. To find optimal states that realise a maximal flux benefit per enzyme investment, we
consider a given flow pattern with predefined flux benefit, and minimise the enzyme cost by screening all possible
states. We can do so in two ways. We may either screen the flows (restricted to a fixed benefit), optimise the
metabolite profile (over the M-polytope – which is an ECM problem), and the pick the flow with the lowest
metabolite-optimised cost; or we screen the metabolite profiles, optimise for each of them the flow (restricted to
a fixed benefit – which is a linear flux cost minimisation problem), and then pick the metabolite profile with the
lowest flux-optimised cost.
Find optimum and determine
enzyme levels and cost
enzymatic metabolite cost
Flux defines For each flux, obtain
enzymatic flux cost
Flux cost minimisation step by step The graphics on the
left shows how metabolic states are screened to compute a
enzymatic flux cost. The aim is to realise a given flow v at
a minimal enzyme cost. Flow pattern, equilibrium constants,
concentration ranges, and given external metabolite levels
together define an M-polytope. Given the flow v, shown as a
point in the flux polytope, each metabolite profile m of the
M-polytope also defines an enzyme profile e and represents
a feasible state of the kinetic model. Using the enzyme
cost as a cost for m, we obtain an optimality problem for
metabolite profiles m on the M-polytope. The resulting mini-
mal value is then assigned to the flow as an enzymatic flux cost.
may be modelled by flux cost functions that increase proportionally to the fluxes. However, the assumption of
linear cost functions and the specific choices of cost weight are often unjustified.
To derive more realistic flux cost functions, justified by detailed biochemical models, I propose to consider the
minimal enzyme and metabolite costs at which a flux can be realised in a given kinetic model (Figure 1). Both
kinds of cost have been considered before (enzyme costs in [15, 6, 16], additional metabolite costs in [17, 18]).
To represent them as flux costs, we need to be able to quantify metabolite and enzyme costs of a given metabolic
flow. To do so, we assume simple fitness terms for enzyme levels, metabolite levels, and fluxes: enzyme costs (see
Box 2) are proportional to enzyme levels (i.e. penalising high enzyme levels), metabolite cost is a convex function
of the logarithmic metabolite levels (e.g. penalising deviations from some ideal metabolite profile), and the flux
benefit is a linear function of the fluxes. We then assume that cells adopt an optimal strategy by maximising
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Box 2: Cost functions for enzymes, metabolites, and fluxes
v
e
c
(a) Cost and benefit terms in metabolism (b) Effective cost functions
Flux benefit b(v)
Enzyme cost h(e)
Metabolite cost q(c)
Enzyme cost h(e)
described as
described as
described as
Enzymatic metabolite cost q   (c)
Kinetic flux cost a   (v)Enzymatic flux cost a   (v)enz
enz
kin
Metabolite cost q   (c)kin
The enzyme cost h(e), originally a function of the enzyme levels, can be cast as an apparent cost function for
metabolite levels (assuming predefined fluxes) or fluxes (assuming that each flow is realised by its privileged
metabolite and enzyme profiles). We obtain three types of cost functions with different arguments, but all of them
describing enzyme cost1 (see graphics above:)
1. Enzyme cost The enzyme cost h = h(e1, e2, ..) scores the enzyme levels directly. We assume a linear enzyme
cost function, implying that each enzyme molecule has a fixed cost (which may nevertheless differ between different
enzymes). What enzyme cost means, and in what units it is measured, may vary from model to model. It may,
for example, refer to enzyme amounts (e.g. enzyme mass per cell dry weight), e.g. when predicting the enzyme
demand of engineered pathways, or to the resulting growth defects2 in units of 1/h (for absolute growth rate
changes) or unitless (for relative growth rate changes).
2. Enzymatic metabolite cost (or “flux-constrained enzymatic M-cost”) The set of thermodynamically feasible
metabolite profiles is a convex polytope in “log-metabolite space” (i.e. in the space of logarithmic metabolite
concentrations). This polytope is called M-polytope PM (or “metabolite polytope”). Its shape depends on details
of the metabolic model and on the flux directions, equilibrium constants, and external metabolite concentrations
(see [8]). Metabolite costs can represent various biological cost functions defined on the M-polytope. The
enzymatic metabolite cost qenz(m;v) = h(e(v,m)) is an overhead cost, describing the enzyme cost h(e) needed
to realise a flow v at the logarithmic metabolite levels m = ln c. It refers to a given kinetic model with given
external metabolite levels and with allowed ranges for the internal metabolite levels. Given a flow v, the enzyme
levels e(v,m) follow directly from the rate laws in the kinetic model and determine the enzymatic cost. Written
as a function of logarithmic metabolite levels, the enzyme cost can serve as an indirect metabolite cost. Since it is
convex [8], the optimal metabolite profile and the ensuing enzyme profiles and enzyme cost can be computed by
convex optimisation3 (see Figure 1). By adding a direct metabolite cost q(m), we obtain the kinetic metabolite
cost qtot(m) = q(m) + qenz(m). If the direct metabolite cost q(m) a strictly convex function, the kinetic
metabolite cost will be strictly convex too, which guarantees a unique optimum for enzyme and metabolite levels.
3. Enzymatic flux cost (or “metabolite-optimised enzymatic F-cost”) Flux cost functions a(v) can be defined ad
hoc, like the linear cost functions used in FBA, or based on kinetic models. Flux cost functions can be defined .
To be biologically plausible, flux cost functions should increase with the absolute flux, i.e., sign(∂a/∂vl) = sign(vl)
whenever vl 6= 0. They may show a jump where a flux switches its sign, i.e. where vl = 0 for some reaction l. The
enzymatic flux cost
aenz(v) = minm q
enz(m;v) = minm h(e(v,m)) (1)
is the minimal enzyme cost at which the flow v can be realised in a given kinetic model (compare Figure 1). If we
also consider a direct metabolite cost, we obtain the kinetic flux cost akin(v) = minm q
tot(m;v), i.e. the minimal
sum of enzyme and metabolite costs at which v can be realised in our model.
the benefit-cost difference, the benefit/cost ratio, or the benefit at a fixed cost, or by minimising cost at a fixed
benefit. By writing enzyme and metabolite cost as functions of the fluxes, we can reformulate such optimality
problems in kinetic models as simple optimality problems for fluxes, leaving enzyme and metabolite levels out of
the picture, but accounting for their effects.
How does this work in practice? A flux mode can be realised by various metabolic states (i.e. states with different
enzyme and metabolite profiles). To score the flux mode, we pick the state with the lowest enzyme cost [16, 8]
or with the smallest sum of enzyme and metabolite costs (“kinetic cost”). Their cost is then assigned to the
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Figure 2: Enzymatic flux cost in a simple branch point model. (a) Model structure. The model can be seen
as a simplified model of central metabolism (see Figure 1), with reactions representing glycolysis (v0), overflow
(v1), and respiration (v2). The concentration of the branch point metabolite is called c, the three external
concentrations are fixed. We consider a kinetic model with substrate-saturated, reversible rate laws. A linear
benefit function b(v0, v1, v2) scores ATP production. The two basic flows vA (red) and vB (blue) are shown
on the right. (b) Enzymatic metabolite cost. Cost functions for basic flows vA and vB (scaled to equal ATP
production rates) are shown in red and blue. Cost functions for mixed flows η vA + (1 − η)vB, interpolating
between the basic flows vA and vB, are shown by black lines. For each flow, the optimum point is shown by a
dot. (c) Cost in flux space. Costs (value from y-axis in (b)) are plotted against the interpolation parameter η,
which varies between 0 (for flow vA) to 1 (for flow vB). The resulting enzymatic flux cost function is strictly
concave (negatively curved) between the two basic flows.
flux mode itself as an “apparent flux cost”. Notably, each flux mode defines an optimal metabolite profile,
but this profile is not required, but privileged by the flux profile, i.e. it is best profile among many (physically
and biochemically) possible choices. The resulting apparent flux cost function can be seen as an overhead cost
because it scores the indirect side-effects (or rather “side requirements”) of the fluxes. Here I will study two cases
of overhead costs: the enzymatic metabolite cost, representing enzyme cost in metabolite space; and the kinetic
flux cost, representing enzyme and metabolite cost in flux space.
Let us see an example. Figure 2 shows the enzymatic flux costs in a simplified picture of central metabolism,
described as a simple branch point (compare Figure 1 (a)). In the model, we assume reversible mass-action
kinetics and fixed flux directions. At given fluxes vl, the enzyme cost depends, effectively, on the logarithmic
metabolite concentration s = ln c. We obtain the formula q(s) = a0
b0−es
v0 +
a1 e
s
es−b1
v1 +
a2 e
s
es−b2
v2. The fluxes
through the branch point can show different flux ratios4, obtained from linear combinations of two basic flows.
In one of the two, the entire flux goes to branch 1; in the other one, the entire flux goes to branch branch 2. All
other flows can be obtained as convex combinations (i.e. by linearly interpolating between the two basic flows).
Figure 2 (b) and (c) show the enzyme cost in metabolite and flux space. In metabolite space, the optimum
value for a mixed flow is always between the curves for the two basic flows ()blue and red). The minimal cost is
achieved by one of the basic flows (in the case shown, vB, blue dot). There cannot be an indifferent optimum
(all black dots at the same height) unless the red and blue curves are completely horizontal and identical.
2.2 Shape of the enzymatic cost flux function
Now we know how to define enzymatic flux cost functions and how to compute them numerically (see Figure 2).
But what are their mathematical properties? Even without an analytical formula to compute them, we can derive
some useful general properties. The enzymatic flux cost a(v) is a nonlinear function on the set of possible flows.
4To compare the two flows, we assume a required flux benefit of 20 ATP molecules per time unit, and we assume that reaction v0
yields 2 ATP molecules (per unit of flux) and v2 yields 18 ATP molecules (per unit of flux); thus, we interpolate between the modes
vA = (10, 10, 0)
⊤ und vB = (1, 0, 1)
⊤. We then consider a range of possible concentrations c in the branch point. For the three
reactions, we consider simple mass action rate laws r0 = 10− s; r1 = s− 0.01, r2 = s− 0.01 and cost weights h0 = 1, h1 = 1, and
h2 = 28.
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This is not the entire flux space, but only on the set of feasible flows allowed by our model, which can further be
restricted to stationary flows. This is the set of flows considered in FBA with thermodynamic constraints. The
cost function is determined by rate laws, parameters, external conditions, and constraints of the kinetic model
considered. A description of such models, model assumptions, and relevant mathematical notions is given in the
SI. Here I focus on models with separable rate laws [20], which cover all typical reversible rate laws and ensure
thermodynamic correctness – i.e. the reaction rates obtained from a given metabolite profile will always have
the right signs, as required by thermodynamics. In the following sections, we sometimes consider the common
modular (CM) rate law, whose graph ν(c) is curved in all directions in log-metabolite space. I further assume
that enzyme cost depends linearly on enzyme levels.
The set of possible flows (see Box 1) is a collection of flux polytopes, each located in a segment of flux space
and realising to a particular flow pattern. Stationarity and thermodynamic constraints limit our flows to some
segments in flux space, which we call “feasible”. A feasible flow pattern corresponds to a segment that contains a
non-empty, convex S-polytope (signed flux polytopes, or PS). If all thermodynamically feasible flow patterns are
allowed, we obtain a collection of S-polytopes, each representing a possible pattern of flux signs (e.g. determined
by given chemical potentials of external compounds). Aside from fixed flux directions, we consider two more
constraints: first, like in FBA, we assume stationary fluxes, which defines a subspace in flux space. Second, to
avoid unrealistically large fluxes, we put bounds on individual reaction fluxes (as in classical FBA) or on linear
combinations of fluxes (as in FBA with molecular crowding). The resulting feasible flows form a convex polytope
in the positive segment of flux space, called the positive polytope (or P-polytope) PP. To avoid complications
caused by flux reversals, we will first assume that the flux directions are fixed and, whithout loss of generality,
non-negative (v ≥ 0); that is, we consider the flux cost function on a single P-polytope.
To explore the possible shapes of a flux cost function, we consider two simple ways in which flows can be varied
within an S-polytope (see Figure 3): we can rescale a flow, or we interpolate between flows of different shapes,
but equal benefit. In the first case, we move between B-polytopes with different benefit values; in the second case,
we move inside a B-polytope5. In each case, the flux cost will vary. If we scale a flow, its cost will scale linearly
(and the flux-specific or benefit-specific cost stays the same). If we interpolate between two flows, the flux cost
is concave on the interpolation line, i.e. equal to the linearly interpolated flux costs, or even higher. In fact, many
flux cost functions are strictly concave on the B-polytope, i.e, the cost of an interpolated flow is higher than
the interpolated cost. Such flux cost functions are superadditive: i.e. the cost a(vA + vB) of a superposed flow
exceeds the sum of costs a(vA) + a(vB). Let us consider these two basic properties, linear scaling and concavity,
in more detail.
With linear enzyme cost functions h(e), the resulting flux cost aenz(v) scales linearly with the flow. This is easy
to see. A given flow v defines an enzymatic cost function qenz(m) on the metabolite polytope. If we scale our
flow v by a factor η, the function qenz(c) will retain its shape, but will be scaled by the same factor η. The
minimum point of this cost function, i.e. the privileged metabolite profile, remains unchanged6. With a constant
privileged metabolite profile, the privileged enzyme profile will scale proportionally to the fluxes, and given the
linear enzyme cost function h(e), also the enzyme cost will scale proportionally. What about the kinetic flux
cost akin(v) under flux scaling? Also the kinetic metabolite cost qkin(m) = q(m) + qenz(m) on the metabolite
polytope remains unchanged. Therefore, a flux scaling will only change the enzymatic flux cost proportionally, but
not the metabolic cost. The kinetic flux cost akin(v), which contains both terms, does not scale proportionally
with the flux, but with an additional offset term: akin(η v) = qopt + η (akin(v) − qopt). Here, qopt is the direct
metabolite cost of the privileged metabolite profile, obtained by minimising the sum of enzyme and metabolite
5When interpolating between flows vA and vB, I call vA and vB “basic” and the interpolated flow “combined”. However, there
is nothing absolute about being “basic” or “combined”: a basic flow may again be combined from other flows, and a mixed flow can
serve as a basic flow to construct other mixed flows.
6If the enzyme cost function h(e) is not linear, but has the form h(e) = h′(
∑
l αl el), with a nonlinear, monotonically increasing
function h′, the privileged metabolite profile also remains unchanged under flux scaling. In this case, the flux cost will not scale
linearly with v, but according to the curve shape of h′.
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Figure 3: The enzymatic flux cost
function aenz(v) is homogeneous and
concave on each S-polytope. (a) The
cost function scales linearly. When
a flow v is scaled by a factor η, its
cost a(v) changes by the same fac-
tor. (b) The cost is a concave func-
tion. If flows vA and vB are ki-
netically distinct, i.e. if they do not
share a privileged metabolite profiles,
the cost function is strictly concave
on the interpolation line between vA
and vB. A linear interpolation of flux
costs (dashed line) can be realised
by splitting the flows in space (cell
compartments) or time (phases of a
metabolic cycle) Then, each flow can
operate under optimal chemical con-
ditions, and flux costs are additive.
costs in metabolite space and independent of flux scaling.
The fact that optimal enzyme levels and enzymatic cost scale proportionally with the fluxes, while the optimal
concentrations remain unchanged, leads to general sum rules for gradients (or “point derivatives”). Since en-
zymatic flux cost scales linearly with the flow, it is a homogeneous function with degree 1: if the entire flow is
scaled by a factor η, the flux cost will scale by η as well (with exponent of 1, hence degree 1). By applying Euler’s
theorem on homogeneous functions, we obtain a sum rule
∑
l
∂a
∂ ln vl
=
∑
l
∂a
∂vl
vl = a (2)
for the point cost avl =
∂a
∂vl
vl =
∂a
∂ ln vl
of individual reactions. With the symbols avl =
∂a
∂vl
, and av: =
∑
l avl ,
we can write the sum rule in the compact form
av: =
∑
l
avl =
∑
l
avl vl = a, (3)
stating that the enzymatic cost a of a flow v is given by the sum of point costs avl , in each point v of the
S-polytope. The sum rule resembles the summation theorems of metabolic control theory, which can be derived
in a similar way. Similar sum rules also exist for derivatives of the optimal metabolite or enzyme levels with respect
to the fluxes (see SI section B.4). Using Eq. (2), we can show that the flux point cost yl =
∂a
∂vl
vl is given by
∂h
∂el
el (proof in SI section E.6). For any flow v, the total enzymatic flux cost is the sum of enzyme point costs of
all reactions, and their sum is given by the enzyme cost h (assuming that h(e) is linear). This may seem trivial,
because the total enzyme cost was already defined as a sum of enzyme costs across all reactions. However, there
is an important distinction: the terms in the sum rule do not refer to a fixed metabolite profile, but account for
the optimal adjustment of metabolite levels as part of taking the derivative! The scaled flux cost a′ (flux cost per
unit flux, or per flux benefit) is homogeneous with degree 0, and we obtain the sum rule
∑
l
a′vl =
∑
l
a′vl vl = 0, (4)
which holds in each point v of the B-polytope. Flux cost functions may be hard to compute: we need to solve an
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optimality problem that depends on all details of the kinetic model and on the enzyme cost weights. However,
using the sum rules (2) and (4), we can prove some general mathematical properties. A similar sum rule for
combinations of flows is discussed in SI section B.4.
We saw that enzymatic flux cost functions scale linearly with the flow. What happens if we interpolate between
flows of different shapes, e.g. if we gradually vary the flux ratio in the branch point in Figure 2? Now, the enzymatic
flux cost may vary nonlinearly. Enzymatic flux cost functions are concave, i.e. the cost of an interpolated flow
will never be lower than the corresponding interpolated cost. This is known from [9], where it has been shown
by a graphical construction, and it can be easily shown if the enzymatic metabolite cost function qenz(m,v)
is continuous, positive, and additive between flows (proof in section B.2). For a large class of models, the
cost function is strictly concave, i.e. the cost will even be higher than the interpolated cost. Whether such a
“compromise cost” arises depends on the rate laws used in the model, which determine the shape of the metabolite
cost function.
To see and example of a strictly concave flux cost function, let us revisit the branch point model in Figure 2.
Why is the cost profile nonlinear? The reason is that the two basic flows privilege different concentrations of the
central metabolite c. If the flows privileged the same concentration, we could interpolate between them by simply
interpolating the enzyme profiles, resulting in linear cost changes. In reality, the two flows privilege different
metabolite levels, and when they are combined, they will operate with one metabolite level that is sub-optimal
for each of them. This makes the flows less efficient and therefore more costly. The cost of a mixed flow is not
just the combined cost of the basic flows, but is higher. Since this argument holds for any two flows on the line
(taken to be “basic” flows), the cost function must be strictly concave.
To study whether flux cost functions are strictly concave, we can use the notion of kinetically distinct flows. Two
flows are kinetically distinct if they privilege different metabolite profiles – or, more precisely, if no metabolite
profile is optimal for both of them. Proposition 3 (in SI section B.3) states: if two flows are kinetically distinct,
the enzymatic flux cost is strictly concave on the line in between (proof in SI section E.4). In contrast, if two flows
are not kinetically distinct, their flux costs are additive and the flux cost function between them varies linearly.
How can we tell whether two flows are kinetically distinct7? For sure, they must have different shapes, because
otherwise they would privilege the same optimal metabolite profile. However, flows of different shapes need not
be kinetically distinct in all cases. For example, if two flows differ only in their use of isoenzymes, and if the
isoenzymes have identical costs and rate laws, these flows will still privilege the same metabolite profile. Of course,
this is an artificial example, but since we can construct such examples, our mathematical criteria need to be able
to rule them out. In fact, with realistic rate laws, differently shaped flows will usually be kinetically distinct. This
holds, e.g. whenever a model’s enzymatic metabolite cost function is strictly convex (Proposition 2 in the SI),
which includes all models with common modular (CM) rate laws [19] or “convenience kinetics” (see SI section
E.5, proof by Joost Hulshof).
[t!]
2.3 Flux cost, enzyme levels, and metabolite levels at points of flux reversal
Until this point, our aim was to optimise the fluxes at given flux directions. Given a flow pattern, a flux benefit
function b(v), and a benefit value b′, we obtained a convex B-polytope and studied the flux cost function on
this polytope. How could we optimise the flux directions themselves? By computing the cost function on all
feasible B-polytopes, we obtain a comprehensive picture of flux costs in the entire flux space. We could consider
7Here are some criteria for two flows vA and vB to be kinetically distinct. (i) The flows must not be scaled versions of each
other. (ii) The flows must not have the same optimal metabolite profile; (iii) If mA and mB are their – possibly non-unique –
optimal metabolite profiles, any variation of these metabolite profiles, at fixed enzyme levels, must change some of the fluxes. (iv)
Any variation of mA and mB at given fluxes will change the necessary enzyme levels.
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Figure 4: Flux cost close to a point of flux reversal. (a) branch
point model with one internal metabolite. (b) Two flows (vA
and vB) with different flow patterns. Given external concen-
trations (shades of magenta, from low-bright to high-dark)
predetermine the flux directions in reactions 1 and 3. Arrow
widths represent reaction rates. The flows are scaled to a
fixed flux benefit (flux in reaction 3). (c) Possible flows, dis-
played as points in flux space. For given chemical potentials
of X (high) and Z (low), and requiring that all reactions be
active, there are two possible flow patterns (S-polytopes, in
colours). Thick lines represent the B-polytopes. (d) Interpo-
lating between flow vA and flow vB. Top: optimal branch
point concentration, as a function of flux v2 (the sweep pa-
rameter). The optimal metabolite and enzyme levels at the
point of flux reversal are changing. Bottom: optimal enzyme
costs (reaction-specific and total) as functions of flux v2, show
a jump as well.
all feasible flow patterns, run FCM for each of them, and pick the best flow among all solutions. This then defines
the best flow pattern.
The enzymatic flux cost is concave on each B-polytope. However, what happens where polytopes touch each
other, i.e. where fluxes change their directions? Within a polytope boundary, the flux cost remains well-defined.
However, as we move between polytopes, the flux cost function may not be continuous, let alone differentiable
or concave8 (for an example, see Figure 4). An explanation for the jump in enzyme and metabolite levels is given
in SI Figure 8.
For each given flux mode, the enzymatic flux cost scales proportionally with the flow. Therefore, when approaching
the point v = 0 (no matter from which direction), the flux cost linearly approaches 0. Since the gradients in the
different directions are different, the flux cost is not differentiable in this point. The kinetic flux cost function
(which includes direct metabolite costs) is not even continuous in this point; it even converges to different values
when approaching v = 0 from different directions, so this function. All this shows, again, that that quadratic flux
cost functions are not a good approximation of flux cost functions, and that linear flux cost functions, different
for each S-polytope, are a more realistic choice.
Let me summarise what we learned so far. Two flows are kinetically distinct in a given kinetic model if their
privileged metabolite profiles differ. The privileged metabolite profiles of two flows will be necessarily different if (i)
the flows have different privileged metabolite profiles and if the underlying (enzymatic or kinetic) metabolite cost
function (on the metabolite polytope) is strictly convex. The latter holds, for example, in models with common
8The enzymatic flux cost cannot be concave on the entire flux space. This is easy to see. We know that starting from the origin
(at v = 0), the cost increases in all (feasible) directions. This wouldn’t be possible if the flux cost function were concave on the
entire set of fluxes.
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modular rate laws, and in models in which any variation δm of the metabolite profile has a kinetic effect on at
least one of the reaction rates. In a model in which all flows on the B-polytope are kinetically distinct, there is
a positive compromise cost and the flux cost function is strictly convex on the B-polytope. All this is shown in
the SI. If flux reversals are allowed, we need to consider the flux cost function on all feasible S-polytopes. At the
polytope boundaries, where flux reversals occur, the metabolite profile may jump from one M-polytope to another
one, leading to jumps in enzymes profile and enzymatic flux cost
3 Flux cost minimisation
Producing biomass (or any pathway product) at a low enzyme cost is an advantage, because it leaves resources
(e.g. protein precursors or cell space) to growth-relevant proteins such as ribosomes. Then the cell can grow
faster or perform extra tasks at a given growth rate. Thus, we assume that cells will choose fluxes that minimise
enzyme cost at a fixed metabolic benefit. We can compute such fluxes by a nonlinear version of FBA, called
Flux Cost Minimisation (FCM) (or Enzymatic Flux Cost Minimization (EFCM), in the case of enzymatic flux cost
functions).
To predict such enzyme-efficient flows, FCM minimises the flux cost a(v) at a given flux benefit b(v) = b′. If
the flux directions are given, we can focus on a B-polytope and minimise the flux cost aenz(v) on that polytope.
If the flux directions are unknown, we may screen all feasible flux sign patterns, compute the best flows, and
pick the best solution. Flux cost minimisation resembles FBA with flux minimisation, except for the nonlineat
flux cost function. Here, we consider the enzymatic and kinetic cost functions derived from kinetic models. For
more general flux cost functions, we require that flux costs are concave and that larger fluxes incur higher costs
(i.e. avl = avl vl > 0 whenever vl 6= 0).
3.1 Cost-optimal metabolic flows
In FCM, we fix a benefit value (e.g. a biomass production rate) and assume that the cell’s task is to realise this
flux benefit at a minimal flux cost a(v). Mathematically, we minimise a(v) on the B-polytope. How can we find
the optimal flows? Within the polytope, flows cannot be linearly scaled (because this would change the benefit
value, which must be fixed in the B-polytope); thus, as long as all flows on the polytope are kinetically distinct,
the cost function is strictly concave and will be minimal in one of the polytope vertices (proof in section B.5).
In many cases, the vertices are elementary flux modes (EFMs). EFMs were originally defined a purely theoretical
concept [21, 22] to describe minimal ways in which metabolic networks can operate. However, studies of optimality
problems such as flux maximisation at a limited total enzyme level and maximisation of enzyme-specific flux
suggested that enzyme-optimal flows must be elementary flux modes9 [9, 11]. Therefore, EFMs are not only
a mathematical tool to characterise possible flows, but they have a biological significance by themselves. They
provide a higher enzyme-efficiency, and therefor a higher biological fitness, than mixed, non-elementary flows.
However, this result holds only for models in which all vertices of the flux polytope are elementary modes! Here
we found that being a polytope vertex, not being an elementary mode, is a condition for enzyme optimality. In
many models, the two properties coincide: as long as flows are constrained by stationarity and flux signs, and
scaled to a single fixed benefit function, the resulting B-polytope will be spanned by elementary flows. In this
case, all B-polytope vertices will be EFMs and our prediction matches the previous predictions. Otherwise, if
there are additional active flux constraints, all polytope vertices will be EFVs, but not necessarily EFMs, and the
shape of the B-polytope (and the set of corners) will explicitly depend on the prescribed flux benefit value b′.
9In the proofs, it is argued that the optimal metabolic state, if it exists, defines an optimal metabolite profile. Then, it is shown
that given this metabolite profile, the cost-optimal flux profile must be elementary.
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Figure 5: Vertices of the B-polytope. (a) Simple example model (metabolic branch point (top) with four ele-
mentary flux modes (EFMs; bottom); all fluxes are constrained to be positive. (b) Feasible flows in flux space
(three dimensions are shown, referring to reactions 1, 2, and 3). The cone of feasible flows is spanned by the
four EFMs. A given benefit value (in the example, v2+ v3 = const.) defines a plane that intersects the cone and
yields a B-polytope (red rectangle), i.e. the set of feasible flows with the given benefit value. The vertices of the
B-polytope are EFMs. (c) If we put an upper bound on the flux v2, all flows with higher v2 values are discarded;
a part of the B-polytope (red rectangle) is cut off and two new, non-elementary vertices emerge (blue circles).
If additional flux constraints are used (aside from normalising the flow to a given benefit value), then each
active flux constraint will cut off some of the polytope vertices, and new, non-elementary polytope vertices will
emerge (see Figure 5). The new vertices will be convex combinations of EFMs. The existence of non-elementary
optimal states is supported by experimental results: in the Crabtree effect, for example, yeast cells often use
respiro-fermentation (a non-elementary flux mode) instead of respiration alone (an elementary flux mode).
A flow is globally optimal if it performs equally well or better than any other flow. In contrast, a flow is locally
optimal if it performs better than any other similar flows. Specifically, a B-polytope vertex is locally optimal if the
flux cost gradient ∇aenz(v), restricted to the stationary subspace, points from the vertex towards the interior of
the B-polytope: in this case, any movement from the vertex into the interior of the B-polytope will increase the
cost. Local optimality can be tested by applying the following criterion (“Segaula criterion”). A vertex point v,
with privileged metabolite profile copt, is locally optimal if and only if v is the only privileged flow of copt. In other
words: metabolite and flux profile must exclusively privilege each other (proposition 5 in SI, proof in SI section
E.7). This criterion is easy to apply: to test a flow v, we run ECM to compute the privileged metabolite profile
copt (which must be unique); then we run linear flux cost minimisation to obtain its privileged flow and check
whether this yields the original flow (which must be unique, too). It also leads to a simple iterative algorithm for
computing locally optimal flows, starting from an initial “seed” flowx (“Segaula algorithm”, see SI section B.6).
3.2 Flux cost minimisation as a generalised form of minimal-flux FBA
How can we find optimal flows in practice? Given a concave flux cost function and a pattern of flux directions,
the optimal flow is a vertex of the B-polytope: to find it, we may enumerate all vertices and choose the one
with the smallest cost. Instead of this exhaustive search, we may directly search for local optima, either by a
greedy search over polytope vertices (e.g. a simplex or amoeba algorithm) or by the iterative Segaula algorithm.
If flux directions are unspecified, we may enumerate all possible flow patters, determine the resulting B-polytopes,
and apply FCM to each of them. By optimising the flow for each feasible flow pattern, we can find the globally
optimal metabolic state of a kinetic model. Altogether, we apply three layers of optimisation: among the flux
patterns, among the vertices of each S-polytope, and among all metabolite profiles within the M-polytope of a
given vertex (see Box 1).
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Enzymatic flux costs are harder to compute and to optimise than the linear cost functions used in minimal-flux
FBA. This becomes problematic if costs need to be computed many times. In flux cost minimisation, we already
need to inspect all vertices of the B-polytope. In flux sampling approaches, we even need to assess flows in
the entire polytope (e.g. to study cell populations in which metabolic flows are randomly distributed, but with a
preference for low enzymatic cost). In both cases, we need to evaluate flux costs many times, and each function
evaluation involves a nonlinear optimisation problem on the M-polytope. To decrease the numerical effort, we
may approximate the enzymatic flux cost by linear or nonlinear functions that are easier to evaluate (see SI section
A.4). Linear approximations of our flux cost functions can also be used to define cost weights for minimal-flux
FBA. Using “capacity-based” enzymatic cost scores in metabolite space [8], we would obtain the same cost
weights as previously proposed. With more realistic cost scores, we obtain nonlinear flux costs. To obtain a linear
approximation, we linearise the cost function around some typical reference flow. The fact that we can derive
linear cost weights from a kinetic model supports the usage of linear flux costs in FBA and justifies linear flux cost
minimisation as a method. The nonlinear approximation is based on multiple prototype flows, covering different
parts of the flux polytope, and yields a quadratic function of the flow.
If linear flux cost minimisation is seen as an approximation of FCM, the linear flux cost weights can be systematically
derived from enzymatic or kinetic flux cost functions, and thus from kinetic models. linear flux cost minimisation
can also be seen as a version of FCM with enzymatic flux costs, but fixed, predefined metabolite levels. In fact,
linear flux cost minimisation is a very smart method: being linear, it is much easier to solve than FCM; and being
convex, it captures a main feature of FCM, the fact that optimal flows are polytope vertices; as model parameters
are changing, its solution will jump between discrete, qualitatively different flows, just like in FCM. However, it
misses (i) the exact values of the cost function on these corners, (ii) the fact that the cost functions are curved,
and (iii) ways to account for metabolite-dependent cost terms.
However, the biggest problem is that the flux cost weights used in linear flux cost minimisation are predefined
numbers, whose relation to biochemistry and external conditions remains unclear. It has been acknowledged
that flux cost weights should reflect kcat values (because lower kcat values, may require higher enzyme levels for
compensation) and enzyme cost weights (e.g. enzyme sizes). However, a flux cost weight may depend on various
other factors. We can see this by deriving flux cost weights from the enzymatic flux cost function, which depends
on other rate constants (e.g. KM values), extracellular metabolite levels, and physiological ranges on intracellular
metabolite levels. Whenever these parameters change, so do the flux cost weights. For example, consider a
model of a respiring cell. If the oxygen level (as a model parameter) decreases, this will affect the shape of the
M-polytope, as well as the enzymatic cost qenz(v), and will therefore alter the enzymatic flux cost function a(v).
The lower driving force will lead to a higher enzyme demand. If we linearise aenz(v) to define realistic flux cost
weights for FBA, the flux cost weights depend on the external oxygen level and on any other model parameters.
The quantitative dependence would be very hard to guess, but using FCM, we can obtain it directly from our
kinetic model. Thus, our simplified linear cost functions do not only justify linear flux cost minimisation as an
approximative method, but they also clarify how quantitative flux cost weights arise from quantitative cell models.
3.3 Flux-specific enzyme cost and cell growth rate
In a metabolic pathway or network, the enzyme investment per flux is an important quantity: it plays a central
role in relating metabolic activity to growth. Cell growth can be linked to metabolism by the following argument:
Under better conditions (e.g., better carbon sources, higher substrate level), the same metabolic flux can be
achieved with a lower amount of enzyme. This allows the cell to increase the flux while decreasing the metabolic
enzyme fraction of the proteome, so the fraction of ribosomes can be increased. The higher fluxes and ribosome
levels allow cells to grow faster. Thus, cell growth depends crucially on the ”proteome efficiency” of fluxes, i.e. the
metabolic flux per enzyme invested (or, equivalently, on the enzyme cost of metabolic fluxes). The proteome
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Figure 6: Metabolic adaptation to varying parameter values. We assume that cells’ “choices” of metabolic flows
result from the minimisation of a convex, concave, or linear objective. (a) If optimal states are determined by
minimising a strictly convex function (e.g. in metabolite cost minimisation), the resulting state will vary smoothly
with changing conditions (parameter axis). (b) If optimal states are determined by minimising a strictly concave
function (e.g. in flux cost minimisation), they will be boundary minima. Under parameter changes, they usually
remain unchanged. Only when different boundary point becomes preferable, the optimal state jumps abruptly to
a new boundary point. (c) A linear objective function (e.g. in minimal-flux FBA) leads to switches, just like a
strictly concave objective. At the switch points, there is an indifferent optimum, i.e. points on an entire line will
be equally good. In reality, biological objective functions may be almost linear, and assuming a linear objective
may be a good approximation.
efficiency will vary between different metabolic strategies (e.g. respiration vs. fermentation), will depend on the
external conditions (e.g. the levels of glucose and oxygen present), and will also depend on a proper allocation of
enzyme resources along metabolic pathways. To predict the growth advantages provided by different metabolic
flows, we need to define the external conditions, find the optimal enzyme allocation pattern, compute the enzyme
investment per (biomass production) flux, and translate it into a maximal possible growth rate (possibly accounting
for necessary resource rearrangements between metabolic enzymes and ribosomes).
Above I assumed that cells minimise their enzyme cost while realising a fixed flux benefit. This is closely related
to the assumption of microbes maximising their growth rate. In order to model fast cell growth as an objective,
we can start from a metabolic model with biomass production and compute, for each flux mode, the maximal
biomass production rate per enzyme investment. This quantity is called enzyme-specific biomass production rate
r. In simplified whole-cell models [12], this quantity is a main determinant of cell growth. Using simple cost-
growth conversion formulae, which translate a flux cost aenz into a cell growth rate λ(a), we can represent cell
growth rate as a function on the B-polytope. Under relatively mild assumptions, this function is convex (see SI
section E.10), and if the flux cost function a(v) is strictly concave, it is strictly convex. This result holds for
any decreasing, convex cost-growth function λ(a), e.g. the formulae published in [12, 10], and it means that
growth rate maximisation can be formualted as the maximisation of a convex function on the convex flux polytope
(implying vertex optima).
4 Switching between metabolic pathways
The shape of a flux cost function determines cells’ preferred metabolic flows. If cells minimise flux cost at a fixed
flux benefit, as assumed in FCM, we can ask what metabolic stategies will emerge, especially if flux cost functions
are strictly concave.
4.1 Parameter-dependent switches between metabolic flows
The optimal metabolic state in a model depends on details such as external concentrations, kinetic constants,
enzyme cost weights, metabolite ranges, flux bounds or biomass production rate. Smooth changes in these
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Figure 7: Zeroth-order and first-order transitions during metabolic switches. At higher biomass production rates,
the limit on respiration may be reached, and respiro-fermentation is performed.
parameters will lead to smooth or abrupt changes in the optimal fluxes, metabolite levels, enzyme levels, and
the resulting growth rate (see Figure 7). Using FCM, we study such changes by screening the model parameters
(e.g. external metabolite levels, rate constants, etc) and computing the metabolic state. As model parameters
change, the shape of the flux cost function (and even the feasibility of different S-polytopes) may change and
another flow may become optimal. Since flux cost functions are concave, the state can only jump from one
polytope vertex to another one. Thus, parameter changes either lead to qualitative changes or have no effect.
This happens at points at which two flows become equally costly. The first case (no flux change upon parameter
changes) makes flux prediction simpler; the second case (sudden flux change upon parameter changes) makes it
more difficult.
Mathematically, we can distinguish three types of metabolic changes. (i) A biochemical model parameter (kinetic
constant or external concentration) changes, but the B-polytope remains unchanged. Even though the flux cost
function changes its shape; the flow remains the same and metabolite and enzyme levels change gradually with
the parameter changes. (ii) The optimum flow jumps between polytope vertices. Such jumps are accompanied by
jumps in metabolite and enzyme levels. (iii) If the changing parameters have a direct effect on the flux constraints
or on the benefit constraint (e.g. a change in the predefined benefit value b′), the S-polytope changes its shape;
polytope vertices can move, and vertices may appear or disappear. This may lead to smooth changes or to abrupt
jumps between vertices.
4.2 Splitting flows in space or time can save enzyme cost
If a cell or organism needs to perform several tasks (e.g. producing different compounds), and if these tasks
require different flows, these flows can either run together as a linear combination or separately, i.e. in separate
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cell compartments or organs, or at different moments in time. The second strategy, “splitting the flows”, can be
cheaper because the compromise cost is avoided (proof in SI section B.2). In Figure 2, we saw that mixing two
flows can lead to a compromise cost because the two flows cannot operate under their respective, optimal kinetic
conditions. If the flows run separately (in different cell compartments, or at different times), each of them can
keep its privileged metabolite profile, and the costs are simply additive. Mixed and split flows achieve the same
chemical conversions; however, they may differ in how easy they are to achieve, what metabolite and enzyme
profiles they require, and, possibly, whether they are thermodynamically feasible at all!
Depending on experimental conditions, yeast grown in continuous cultures can show spontaneous metabolic
oscillations involving periodic changes between respiration and fermentation, as observed in budding yeast [23,
24, 25]. Such oscillations allow cells to separate incompatible processes in “temporal compartments” in order to
use them more efficiently or to reduce deleterious side effects (e.g. avoiding DNA synthesis during phases with
high cellular levels of reactive oxygen species) [24]. In theory, metabolic processes may be incompatible due to
thermodynamics (because running them simultaneously would require thermodynamically impossible loops) and
become compatible only when they are split. However, even if processes are not strictly incompatible, splitting
them may reduce enzyme cost (i.e. avoid compromise cost) because this makes them thermodynamically or
kinetically more favourable. Other splitting strategies (like spatial splitting in organelles, or division of labour
between cells) can provide similar benefits.
Generally, if a flux cost function is strictly concave, splitting the flows can provide an advantage.If a metabolic
flow v is a convex combination v = η vA + [1 − η]vB of kinetically distinct metabolic flows vA and vB, it will
be cheaper to split the two flows in space (in different compartments, cells, or organs), or time (in alternating
phases with relative durations η and [1 − η]) than to run them constantly as a convex combination (“combined
flow”). This affects the metabolic strategies used by cells. In theory, flows could be split further and further into
combinations of elementary or non-elementary modes, e.g., MinModes [26] which run some basic “housekeeping”
processes together with specific metabolic processes.
Why can splitting the flows provide an advantage? Because each flow can run at its own optimal metabolite
profile without any compromise cost. There may even be cases in which a splitting of flows is the only way to
make them thermodynamically feasible (e.g. by running some reactions in cell compartments with different pH
values). However, this fact is already included in our previous argument: as shown in [8], poor thermodynamics
leads to high enzyme cost, whereas impossible thermodynamics leads infinite enzyme cost. Whether splitting a
flow will pay off depends on many factors, e.g. on how strongly the flux cost function is curved, and on extra
costs for maintaining cell compartments, or achieving the temporal metabolic switches. If these extra costs are
too high, splitting the flows will not be profitable.
4.3 Metabolic switches as economic phase transitions
When model parameters are smoothly changing, the optimal metabolic state (fluxes, metabolite levels, enzyme
levels) may vary smoothly or sometimes abruptly. In physics, a qualitative change in a system’s state upon a
smooth change in the system parameters is called a phase transition. A metabolic switch, the abrupt change
from one optimal flow to another one, is an example of a zeroth-order phase transition because fluxes, metabolite
levels, and enzyme levels show abrupt changes in their values, not only in their derivatives. However, they are not
phase transitions (or bifurcations) in the usual dynamical sense: since they also involve an optimal choice, one
might call them “economic bifurcations”. Mathematically, they resemble phase transitions in thermodynamics
where the system state (and possibly phase separation) is determined by an “optimality” principle, the principle
of minimal Gibbs free energy.
So far, we considered switches between simple steady states, i.e. jumps between polytope vertices. However,
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cells may also split flows in space or time, and thus employ phase separation behaviour. Such switches between
complex strategies correspond to another type of phase transitions in classical thermodynamics: phase separation.
Instead of switching from one homogeneous phase to another one, the system (e.g. a volume filled with water)
switches to a coexistence of phases (e.g. water and ice), which together minimise the Gibbs free energy. Likewise,
the metabolic state of a cell may undergo a phase separation, leading to a split flow.
5 Discussion
The enzymatic flux cost a(v), or “enzyme cost in flux space”, refers to a given kinetic model and describes
the minimum enzyme cost at which a flow v can be realised. The kinetic flux cost contains an extra term
for metabolite cost, which has an impact on optimal metabolite and enzyme levels and also on enzyme cost.
Flux cost functions may be difficult to compute and their shapes depend on details such as kinetic constants,
external metabolite levels, and metabolite bounds. Here we found some simple general properties: flux costs are
not additive; whenever two flows are kinetically distinct (i.e. they privilege different metabolite profiles, which is
usually the case), there is an extra “compromise cost”. The compromise cost reflects the fact that the mixed
flow privileges a different metabolite profile than the original basic flows. The compromise cost vanishes only if
the basic flows already privilege the same metabolite profile. Therefore, enzymatic flux costs scale linearly with
the metabolic flow, are concave on the S-polytope, and are strictly concave between kinetically distinct flows.
Optimal flows are vertices of the flux polytope. They often represent elementary flux modes and can be computed
by flux cost minimisation. Finally, strictly concave flux cost functions imply a compromise cost, which cells can
avoid by splitting their flows. This provides an incentive for (spatial or temporal) compartmentalisation.
In this article, flux cost functions were used in a specific type of optimality problems: minimisation of cost at a
fixed flux benefit. Since cost and benefit scale linearly with the flow, this optimisation is equivalent to minimising
the cost/benefit ratio for metabolic flux modes (whose absolute scaling, by definition, remains undetermined).
However, the equivalence only holds if also all active flux constraints (e.g. upper bounds on individual fluxes) are
independent of such a scaling. Flux cost functions can also be used in other approaches, for example, maximising
a flux benefit at a given flux cost (similar to FBA with molecular crowding). The cost/benefit ratio is an important
quantity because it affects the growth rate of cells. If additional constraints are imposed (e.g. a constraint on
respiration capacity, due to crowding of respiratory chain proteins on cell membranes), the absolute scaling of
flows will matter in fact, and we need optimisation methods in which the absolute scaling of flows plays a role.
As an even more general approach, we could treat enzyme cost, biomass production, and objectives like biomass
yield by multi-criteria optimality [27].
In a cell population, different cells may show different flows. We may assume a random distribution of flows
leading to different growth rates, and therefore different evolutionary advantages. Knowing the shape of a
flux cost function, what would we expect about this distribution? The growth rates assigned to metabolic
flows can be converted into selection coefficients (i.e. [growth rate mutant - growth rate resident]/ [growth
rate resident] or equivalently, log(growth rate mutant) - log(growth rate resident)). Using simple assumptions
about population dynamics, we can translate the selection coefficient (as a function on the flux polytope) into
a probability distribution on the same polytope. For example, treating flux cost as an “energy function”, we
may assuming a Boltzmann distribution on the set of possible flows. Using approximate (linear or quadratic
flux cost functions, these Boltzmann distributions will be exponential, or Gaussian, respectively. Using these
distributions, we may sample from them to compute average fluxes, flux variability, and flux correlations in a
population ensemble.
Sometimes, minimisation of enzyme cost may not play a dominant role in determining cellular states. For
example, in a metabolic switch experiment, Lactococcus lactis bacteria were found to retain apparently “useless”
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protein levels even though a decrease, at the same fluxes, would have been possible [28]. An extra investment
in proteins may allow cells to quickly adapt to new situations, or enzymes may have additional functions or
benefits (e.g. serving as a storage of amino acids), which are neglected in the optimality problems considered
here. Nevertheless, it can be helpful to know the theoretical minimal cost of a flux, and the corresponding
maximal growth rate, assuming that there are no other side-objectives. Thus, the present simple approach can
serve as a “baseline model” for more advanced optimality approaches that will capture preemptive expression,
further side objectives for proteins or metabolites, or actual deviations from optimality.
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Supplementary Information
A Metabolic flows and flux cost functions
To describe metabolic flows and flux cost functions, I use the following terminology.
A.1 Metabolic models and metabolic flows
Metabolic models We consider kinetic models with reversible rate laws of the form vl = el r(c). The catalytic
rate r(c) can be separated into capacity, reversibility, saturation, and regulation factors [8]. To score a metabolic
state, we consider three fitness objectives: b(v) (linear flux benefit function), q(c) (concave metabolite benefit
function), and h(e) (linear enzyme cost function). Typically, flux benefits describe the production of valuable
compounds or biomass, and the enzyme cost describes growth disadvantages from higher protein levels. From
the ratio [enzyme cost]/[flux benefit], estimates of the cell growth rates can be derived (see section E.10).
Metabolic flows, scaled flows, and flux modes Stationary flux distributions v, satisfying the stationarity
conditionNv = 0, are also calledmetabolic flows. If we disregard the absolute scaling of v, we obtain a flux mode,
which can also be represented by a scaled flow. For example, with a reaction flux vr (e.g. biomass production)
chosen as our “target flux”, we can define the scaled flow v/vr and the overall flux cost a
′(v) = a(v)/vr , i.e. the
flux cost per target flux. Likewise, we can scale all flows to the same (linear) flux benefit. If a flow v is multiplied
by some factor η, its scaled cost remains unchanged. An elementary flux mode is a flux mode with a minimal
set of active reactions: if one more reaction flux were restricted to be zero, the remaining set of active reactions
would not support any stationary flux distribution anymore.
Flow patterns and conformal flows The sign vector of a flow v, a vector with elements 1,0, and -1, described
the set of active reaction and flux directions. Generally, such vectors are called flow patterns. A flow or a flux
mode conforms to a flow pattern if all active fluxes match the prescribed signs (i.e. zero fluxes are allowed even
where signs 1 or -1 are prescribed). A flow v has (or “strictly conforms to”) a flow pattern if the flux signs
exactly match the prescribed signs (in this case, a prescribed sign of 0 means that the flux must vanish). Two
flows are called conformal if they conform with a common flow pattern, i.e. if all their shared active reactions
show the same flux directions. Two flows are strictly conformal if they have exactly the same flux pattern. All
these definitions also hold, mutatis mutandis, for flux modes instead of metabolic flows.
Feasible flow patterns Among the possible flow patterns in a metabolic model, only some are physically and phys-
iologically feasible. To be kinetically realisable (with reversible rate laws), a flow must be thermo-physiologically
feasible, i.e. it must be possible to realise the fluxes, satisfying the thermodynamic constraint on flux directions
and with a choice of metabolite levels that respect the physiological concentration ranges defined in the model.
If a flow is thermo-physiologically feasible, then its flow pattern is called thermo-physiologically feasible as well.
Briefly, in our terminology, a feasible flux sign pattern is a flow pattern that allows for fluxes that conform to this
flow pattern, are stationary, thermodynamically feasible, and realise the predefined flux benefit.
A.2 Flux polytopes and metabolite polytopes
Flux polytopes Each flow pattern corresponds to a segment in flux space, i.e. an orthant or a lower-dimensional
surface of an orthant. If a segment is cut by the subspace of stationary fluxes, the resulting set is called an S-
polytope (“signed flux polytope”) PS. If the flow pattern forbids negative fluxes, the corresponding S-polytope
is called a positive flux polytope PP = {v|Nv = 0;v ≥ 0}. If two flows are conformal, they will belong to the
same S-polytope. All flows in the interior of an S-polytope are strictly conformal.
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Benefit-scaled polytope By restricting an S-polytope to flows with a fixed benefit b(v) = b′, we obtain a
B-polytope (“benefit-restricted flux polytope”), which is convex and lower-dimensional than the S-polytope10.
Feasible flux sign patterns correspond to segments of flux space that contain non-empty B-polytopes, for the
kinetic model, concentration ranges, and flux benefit function in question.
Metabolite polytope Flow patterns do not only define an S-polytope for fluxes, but also a corresponding metabo-
lite polytope PM for thermo-physiologically feasible metabolite profiles: it is the set of (natural) log-concentration
vectors m = ln c that are thermodynamically feasible for the given flux directions and bounds on individual con-
centrations. In a given metabolic model, each flow pattern defines an S-polytope and an associated M-polytope.
Reorienting the reaction directions The flux signs in models are a matter of convention. They depend on
how the reactions are formulated, i.e. which compounds are treated as substrates or as products. Due to this
arbitrariness, an S-polytope can always be converted into a P-polytope by reorienting the reactions. Whenever
we consider flows with a predefined flow pattern, we can assume (without loss of generality) that the fluxes are
non-negative. All statements about enyzyme or metabolite levels (in particular, the convexity proof for enzyme
cost functions on the M-polytope and the concavity prrof for flux cost functions on the P-polytope) remains valid
after reorienting the fluxes.
Mixed flows With two flows vA and vB and an interpolation parameter 0 < η < 1, we can form the mixed
flow vC = η vA + [1− η]vB; in this combination, the flows vA and vB are called the basic flows. Combinations
of three or more flows are defined accordingly. If several flows belong to one S-polytope, their mixed flows will
all belong to the same S-polytope. If flows belong to one B-polytope, their mixed flows will belong to the same
B-polytope.
A.3 Flux cost function and compromise cost
Definition A.1 Flux cost functions We consider a kinetic model with metabolite cost q(m) and enzyme cost
h(e) and define
qenz(m;v) = h(e(m;v)) (Enzymatic M-cost)
qkin(m;v) = h(e(m;v)) + q(m) (Kinetic M-cost)
aenz(v) = minm q
enz(m;v) (Enzymatic F-cost)
akin(v) = minm q
kin(m;v) (Kinetic F-cost), (5)
where the log-metabolite profile m = ln c contains the logarithmic metabolite levels and the enzyme demand
e(m;v) is the enzyme profile that is needed to realise the flow v with the log-metabolite profile m.
Definition A.2 Concave flux cost functions A flux cost function on a B-polytope is concave if it satisfies, for
all vA and vB from the B-polytope and for all η ∈ [0, 1],
∀η ∈ ]0, 1[: a([1− η]vA + ηvB) ≥ [1− η] a(vA) + η a(vB). (6)
Eq. (6) states that the enzymatic flux cost a(vC) of the interpolated flow vC = [1−η]vA+η vB (where 0 < η < 1)
is equal or larger than the (additive) combined cost qinterp = [1 − η]a(vA) + η a(vB). If a flux cost function
satisfies Eq. (6) with > instead of ≥ signs, it is called strictly concave.
Remarks
10One may also apply several benefit constraints (i.e. a set of equalities Bv = b′), but we do not consider such cases here.
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1. Scaled flux polytopes In the definition above, the “benefit function” defining the B-polytope need not by
biologically motivated. It can be any linear function used to establish a unique scaling of flows.
2. Compromise cost A concave flux cost function can be split into an additive combined cost plus a non-negative
compromise cost. If a flux cost function is strictly concave, the compromise cost will be positive.
3. Cost of mixed and split flows A combination of flows vA and vB on one S-polytope can be realised in two
ways: as a mixed flow (a weighted sum of the two flows), or as a split flow. The enzymatic flux cost is a
concave function, so the cost of a mixed flow v =
∑
α ηα v
(α) (with coefficients 0 ≤ ηα ≤ 1) will always be
at least as high as the combined cost alin(v) =
∑
α ηα a(v
(α)). In many cases, it will be strictly concave, and
there will often be an additional positive compromise cost. However, the combined cost can be achieved by
splitting the mixed flows, and running the basic flows separately in different cell compartments or at different
times (with relative durations η and 1 − η). In this case there is no compromise cost, and costs of the flows
are additive.
A.4 Linear and nonlinear approximations of enzymatic flux cost functions
Linear approximation of the enzymatic flux costs To obtain a linear flux cost function with realistic cost
weights, we linearise the enzymatic flux cost around a reference flow vref . The approximation works best near the
reference flow (or, more precisely, for flows v that privilege similar metabolite profiles as the reference flow itself).
Therefore, vref should be “typical”, resembling the flows for which a(v) will be computed. The cost gradient in
a point v is given by
∂a(v)
∂vl
=
hel e
opt
l (v)
vl
, (7)
where eoptl (v) is the optimal enzyme profile realising our flow v (see SI E.8 and E.6). Equation (7) holds for
kinetic flux cost functions as well (i.e. cost functions that include a direct metabolite cost). By linearising the
cost function around the reference state vref , we obtain the linear approximation
a(v) =
∑
l
∂a
∂vl
vl ≈
∑
l
(
∂a
∂vl
)
vref
vl =
∑
l
avl vl (8)
with flux weights avl =
hel e
opt
l
(vref )
vref
l
=
hel
rref
l
. There is no offset term, and this makes in fact sense: otherwise,
our approximated cost function (unlike the original cost function) would not be linearly scalable. The formula
(8) holds only for P-polytopes (i.e. where non-negative fluxes are required). For other S-polytopes, with negative
fluxes, we may reorient the reactions and obtain the same formula, but with different prefactors (obtained from
different reference flows). The signs of these prefactors match the flux signs. If we assume the same (absolute)
prefactors for all S-polytopes, we obtain the formula qlin(v) =
∑
l avl |vl|, the formula assumed by linear flux cost
minimisation. The linear approximation (8) leads to linear flux cost weights for linear flux cost minimisation or
FBA with molecular crowding. Not surprisingly, the linearised flux cost function is exact for the reference flow
and scaled versions of it. For other flows, the approximation error depends on how much the specific rates (vl/el,
for optimised enzyme levels) differ between v and the reference flow vref .
Nonlinear approximation of flux cost functions, based on prototype flows For a nonlinear approximation, , we
join information from several prototype flows v(α). To approximate the cost a(v), we first approximate our flow v
by a convex combination v ≈
∑
α ηα v
(α) of the prototype flows (with positive weights ηα satisfying
∑
α ηα = 1).
Then we use these weights ηα to define a weighted average of the inverse specific rates 1/r
′
l =
∑
α ηα/r
(α)
l . We
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obtain the approximated flux cost (see apendix E.9)
anon(v) ≈
∑
l
hel
r′l
vl =
∑
lα
ηα
r
(α)
l
hel vl. (9)
This flux cost function is nonlinear in v because the prefactors 1/r′l are weighted averages of the prototype
flows’ 1/rl, with weights depending on v. As shown in section E.9, this cost function is quadratic. If we use
a single prototype, the curvature vanishes and we reobtain the linear approximation. To improve the quadratic
approximation (9), it is more important to use prototype points close to v, the flow of interest, than many prototype
points elasewhere. In fact, considering additional prototype points far from v may worsen the approximation.
B Mathematical properties of flux cost function
In this section, I first discuss the conditions under which enzymatic M-cost functions have a unique minimum
point. Then, I show that enzymatic flux cost functions are concave on the S-polytope and strictly concave when
interpolating between kinetically distinct flows.
B.1 Shape of the enzymatic metabolite cost function
Conditions for strictly convex metabolite cost functions Under certain conditions, we can prove that the
enzymatic M-cost will be strictly convex on the metabolite polytope. In a given point of the M-polytope, the
enzymatic metabolite cost function will be positively curved in some directions and constant in others, These
“cost-neutral” directions are due to the structure of the model and the rate laws used. To see this, we consider
the Hessian matrix of the enzymatic M-cost function, which I call the cost curvature matrix H. If H is positive
definite (i.e. regular), the enzymatic metabolite cost is strictly convex on the M-polytope, and the ECM problems
has a unique solution. By contrast, if H has vanishing eigenvalues (i.e. it is singular), the enzyme cost function is
non-strictly convex, and the ECM problem has a subspace of solutions. To see whether a cost curvature matrix
is regular, we need to determine the cost-neutral subspace of the model.
Shape of the enzymatic metabolite cost function A given flow v defines a feasible M-polytope, and each
metabolite profile m in this M-polytope defines a feasible metabolic state. Optimal profiles are determined by
the shape of the enzymatic M-cost function on the polytope. There are two cases: a cost function can be strictly
convex (with a regular cost curvature matrix on the entire M-polytope), with a single optimal metabolite profile;
or there exist directions of constant cost in metabolite space (i.e. the cost curvature matrix will have a non-empty
nullspace), and there is a whole set of optimal metabolite profiles along these directions. Whether such “cost-
neutral” directions exist depends on the model’s network structure and type of rate laws. Thus, to see whether
the ECM problem has a unique solution, we need to check for “cost-neutral” metabolite variations δm that leave
enzymatic metabolite cost unchanged, no matter in what metabolic state they are applied.
Cost-neutal variations and the nullspace of the cost curvature matrix matrix Let us look at the enzymatic
metabolite cost function qenz(m) and its curvature matrix matrixH more closely. If qenz(m) stems from separable
rate laws, H will have the following properties (proof in section E.2):
1. H is positive semidefinite (proof in SI E.4)
2. Given a flow v, the cost curvature matrix of the enzymatic metabolite cost in a point m can be split into
contributions from the single reactions H(m;v) =
∑
lH
(l)(m;v). Each of these cost curvature matrixs is
positive semidefinite (because the enzymatic metabolite cost for each reaction is convex), and the nullspace
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of H is the intersection of all nullspaces of the matrices H(l). If this intersection is empty, H will be regular.
This happens, for instance, in models with CM rate laws (proof see section E.5).
3. The nullspace Ker(H) is structurally determined, i.e. determined by rate laws and network structure only, and
is independent of m and v (here, a fixed flow pattern of v, with strictly defined zero values, is assumed).
4. Let vA and vB be two flux modes in the same S-polytope, and mA and mB be the respective optimal
metabolite profiles. Then the cost curvature matrices in the points (vA,mA) and (vB,mB) have identical
nullspaces.
5. In models with reversibility-based rate laws [8], Ker(H) is the nullspace of the transposed stoichiometric matrix
N⊤; in models with saturation-based rate laws, Ker(H) is the nullspace of the molecularity matrix
(
MS
MP
)
; in
models with CM rate laws, Ker(H) is empty, i.e., H is regular (proof in section E.5).
Conditions for a singular cost curvature matrix Under what conditions will the cost curvature matrix be
singular, resulting in non-unique optimal metabolite profiles?
1. If a metabolite i does not affect any of the reaction rates. Then any variation vector δm = (0, 0, .., δmi, 0, 0)
⊤,
with an entry at position i is a nullvector of H.
2. If the rate laws do not directly depend on metabolite levels, but only on thermodynamic forces. The thermo-
dynamic driving forces are given by Θl = −RT
∑
nil ln ci. If the rate laws depend on these forces only (for
holds, e.g. for the “reversibility-based” rate laws in [8]), then any variation δm that leave the driving forces
unchanged is a nullvector of H. Such vectors δm are given by the nullvectors of N⊤tot (i.e. conserved moiety
vectors).
3. If the rate laws do not directly depend on metabolite levels, but only on mass-action products. The mass-
action products are given by
∏
i c
mS
li
i or
∏
i c
mS
li
i , with molecularities in the matrices M
S and MP (e.g. the
“saturation-based” rate laws in [8]). Variations δm that do not affect the mass-action products are nullvectors
of H. Such vectors δm are given by the nullvectors of
(
MS
MP
)
.
4. If there exist variation vectors δm that do not affect any of the reaction rates. A reaction l defines, by its
enzyme cost, a cost curvature matrix H(l) with a nullspace Ker(H(l)). The nullspace of H is the intersection
of all these nullspaces. A variation that is cost-neutral for each reaction is therefore a nullvector of H. In
contrast, if any possible variation δm affects at least one reaction, then H is regular.
Thus, nullvectors of the cost curvature matrix may arise structurally, from rate laws and network structure alone.
In fact, for models with separable rate laws (and non-constant thermodynamic and kinetic efficiency factors), the
entire nullspace of the cost curvature matrix arises in this way. This is stated by the following lemma (proof in SI
section E.3).
Lemma 1 (The nullspace of the enzymatic metabolite cost curvature matrix is given by the cost-neutral
subspace) In models with separable rate laws (and non-constant thermodynamic and kinetic efficiency factors), all
neutral metabolite variations δm are nullvectors of the cost curvature matrix H and, conversely, every nullvector
of H is a neutral metabolite variation. This holds in any point m of the M-polytope. A nullvector of H in a
point m is also a nullvector of H in any other point.
Thus, given a kinetic model (network structure, rate laws, and model parameters) and a flow pattern, the nullspace
of the cost curvature matrix is structurally determined and is independent of the metabolite profile m and the
flow v.
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Remark According to Lemma 1, if a model has an empty cost-neutral subspace, the enzymatic metabolite cost
is strictly convex on the M-polytope and the ECM problem has a unique solution. This holds, in particular, in all
models with common modular rate laws, because their cost-neutral subspace is empty (proof in SI section E.5).
Two metabolite profiles mA and mB are called cost-equivalent if their difference vector mA−mB is cost neutral,
i.e. in the cost-neutral subspace. To obtain a practical test, we introduce the notion of rate equivalence. Rate
equivalence is defined as follows. With unit enzyme concentrations el = 1, the metabolite profile mA will yield
the reaction rates ν(m,1). We now ask whether changing from mA to mB, at fixed enzyme levels, will change
these reaction rates. If there is no change, mA and mB are rate-equivalent. Rate-equivalent metabolite profiles
are also cost-equivalent.
B.2 The enzymatic flux cost is a concave function on the S-polytope
Lemma 2 Concacve flux cost functions (proof in SI section E.1) Consider a cost function f(m;v) that depends
on metabolite profiles m (in the M-polytope), is linear in the fluxes v (in the S-polytope), f(m;αvA + β vB) =
αf(m;vA) + β f(m;vB), and is bounded from below. Let g(m) be a cost function on the M-polytope that
is also bounded from below. Then the flux cost function a(v) = minm∈PS f(m;v) + g(m) is concave on the
S-polytope PS.
From Lemma 2, we obtain
Proposition 1 (Enzymatic flux cost is a concave function)The enzymatic flux cost aenz(v) = minm q
enz(m;v)
and the kinetic flux cost akin(v) = minm q
enz(m;v) + q(m) are concave functions on the S-polytope.
Remarks
1. Linear enzyme cost function In Lemma 2, the enzymatic metabolite cost function qenz(m;v), must be
linear in the fluxes; this requires that the enzyme cost function h(e) is also linear. If h(e) has a more general
form f(g(m,v)), where f(·) is increasing and convex and g(m,v) is linear in the fluxes, the enzymatic flux
cost function may not be concave.
2. Non-stationary fluxes Proposition 1 holds not only for stationary, but also for non-stationary flux distributions.
In this case, we only require that the flux distributions vA and vB and all their interpolations must be
thermodynamically feasible for the equilibrium constants and external metabolite concentrations in our model.
Let us consider one thermodynamically feasible flux sign pattern. If non-stationary flux distributions are
allowed, then any flux distribution in the positive orthant OP = {v|v ≥ 0} can be a solution. Since the flux
cost is concave on this orthant, it is also concave on all B-polytopes within this orthant.
B.3 The enzymatic flux cost is strictly concave between kinetically distinct flows
The enzymatic flux cost is not only concave, but in many models strictly concave on the B-polytope. This means:
the costs of flows are not simply additive; instead, mixed flows contain an additional, positive compromise cost.
The most general criterion for strict concavity is that all flows on the B-polytope must be kinetically distinct.
Definition B.1 Kinetically distinct metabolic flows Consider two strictly conformal metabolic flows vA and
vB (i.e. flows with the same active reactions and flux directions). The flows are kinetically distinct for a given
kinetic model if they privilege necessarily different metabolite profiles, i.e. if there is no metabolite profile that is
cost-optimal for vA and vB.
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Remark Why does the word “necessarily” appear in this definition? If each flow privileges a single metabolite
profile only (i.e. if the enzymatic M-cost function is strictly convex.), then flows with different privileged profiles
are kinetically distinct. However, a flow may also privilege several metabolite profiles (if the solution to the ECM
problem is not unique). In this case, the criterion requires that no single profile may be privileged by the two
flows.
Proposition 2 Consider a kinetic model and a flow pattern. If the enzymatic M-cost is strictly convex (on the
M-polytope), then all fluxes on the B-polytope are kinetically distinct.
With this definition, we can now state: an enzymatic flux cost function will be strictly concave on the B-polytope
if (and only if) all flows in the B-polytope are kinetically distinct(proof in SI E.4). To prove this statement,
we consider metabolic models with given rate laws and flux directions and analyse the resulting ECM problem.
We assume that the external metabolites have fixed concentrations and the internal metabolites have variable
concentrations to be optimised.
Proposition 3 (Conditions for strictly concave flux cost functions) Let a(v) be an enzymatic flux cost
function on a P-polytope. If vA and vB are kinetically distinct flows in the interior of that polytope, then a(v)
is strictly concave on the line between vA and vB (proof in section E.4).
Remarks
1. The condition also holds for combinations of multiple flows vA,vB,vC ... Instead of a line, we consider the
simplex spanned by the flows (i.e. their convex hull).
2. Strict concavity also holds for kinetic flux cost functions (i.e. flux cost functions that contain direct metabolite
costs) if the following conditions are satified: the kinetic metabolite cost q(m) (i.e. enzymatic plus direct
metabolite cost) must be convex and its cost curvature matrix must have the same nullspace everywhere in
the M-polytope. In this case, adding it to the enzymatic metabolite cost may change the cost curvature
matrices, but these matrices, in the entire M-polytope, will still have the same nullspaces. Therefore the
concavity proof in SI E.4 still applies.
Corollary 1 If all flows in a B-polytope are kinetically distinct, the enzymatic flux cost a(v) is strictly concave
on the interior of this B-polytope.
By combining Proposition 2 and Corollary , we obtain the following proposition.
Proposition 4 We consider a kinetic model and prescribe a feasible flow pattern. If the enzymatic M-cost is
strictly convex on the M-polytope, the enzymatic flux cost a(v) is strictly concave on the interior of the B-polytope.
Typically, different metabolic flows will be kinetically distinct. However, let us see some flows that are not
kinetically distinct and for which the flux cost function varies linearly on the line between the two flows.
1. Flows that differ only by scaling The enzymatic flux cost scales linearly with the flow. Therefore, if two
flows vA and vB are identical except for their absolute scaling, the flux cost is not strictly concave on the
interpolation line.
2. Flows that employ nominally different (but practically equivalent) chemical reactions The enzyme
molecules catalysing a reaction R may be arbitrarily assigned to two pools (E1, “blue” enzyme molecules) and
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(E2, “red” enzyme molecules), and our reaction may be formally represented by two reactions with identical
properties, R1 (catalysed by blue enzyme) and R2 (catalysed by red enzyme). Since the subdivision is a
pure matter of description and has no effect on the system dynamics, it cannot change the flux cost. Thus.
reactions R1 and R2, as well as any convex combination, have the same cost; the cost function is constant
between R1 and R2 and therefore not strictly concave.
In these examples, the flows vA and vB, privilege the same metabolite profile. Therefore, the interpolated flows
can be optimally realised by a linear interpolation of the enzyme levels; for linear cost functions h(e), this implies
a linear change in enzyme cost. Thus, for strict concavity to hold, our basic flows must not privilege the same
metabolite profile. However, if the optimal metabolite profiles are not uniquely determined, i.e. if a flow can
privilege several metabolite profiles, will strict concavity still hold?
1. Flows that privilege kinetically equivalent metabolite profiles. In some models, different metabolite
profiles mA and mB may yield the same reaction rates at the same enzyme levels, and the same reaction
rates may occur for all metabolite profiles on the line between mA and mB. As an example, consider two
reactions A ⇔ B + C ⇔ D with reversible mass-action kinetics. If [B] is scaled by a factor 10 and, at the
same time, [C] is scaled by a factor 0.1, the reaction rates remain unchanged. In the metabolite polytope (on
logarithmic scale), we can linearly interpolate between two metabolite profiles. This is a case in which rates
(and therefore cost) remain constant on a subspace in log-metabolite space, indicated by a nullvector of the
cost curvature matrix of qenz(m;v).
2. Metabolites that do not affect any of the reaction rates As a second case, we may consider models in
which some reaction rates are independent of all metabolite levels. This holds for “capacity-based rate laws”
[8], describing enzymes that are completely substrate-saturated and forward-driven. In models containing such
rate laws, even small enzyme perturbations can make a steady state impossible. In such models, it is also
likely that some metabolites have no actual impact on reaction rates. A similar case occurs in models in which
certain metabolites formally appear, but do not participate in any reactions.
In these two examples, the privileged metabolite profiles of our flows are not unique. However, there are still flows
that can privilege the same metabolite profiles. In this case, when interpolating between two flows, one could
obtain different metabolite profiles, and still realise the flux changes by linear changes in enzyme levels (i.e. at
varying metabolite levels, but constant specific rates!). Therefore, whenever two flows can privilege the same
metabolite profiles, we do not regard them as kinetically distinct.
B.4 A sum rule for the enzymatic costs of mixed flows
The sum rules Eqs (2) and (4) for absolute and scaled enzymatic flux cost functions can be obtained from Euler’s
theorem on homogeneous functions. Similarly, we obtain sum rules for the derivatives of the optimal metabolite
or enzyme levels with respect to the fluxes:
∑
l
∂copti
∂ ln vl
=
∑
l
∂copti
∂vl
vl = 0.
∑
l
∂eoptl
∂ ln vl
=
∑
l
∂eoptl
∂vl
vl = e
opt
l . (10)
At first glance, Eq. (2) seems to state something obvious: that the total enzyme cost of a flow consists of the
sum of enzyme costs a(v) =
∑
l h(el). However, the two statements differ in one point: the derivatives
∂a
∂vl
in
the sum rule are not derivatives ∂qenzl (v,m)/∂vl assuming fixed metabolite levels. Instead, they imply an optimal
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metabolic adjustment whenever fluxes are changing. This reflects an important difference between our enzymatic
flux cost function and simple flux costs as in FBA with molecular crowding, which assume a proportionality
between enzyme levels and stationary fluxes, as if metabolite levels were constant and independent of the choice
of enzyme levels and fluxes. Our sum rule acknowledges that fluxes and enyzme levels are globally coupled through
metabolite levels, whereas simple flux costs are assumed to be additive between reactions11. We can formulate a
similar sum rule for flows that are represented by convex combinations v =
∑
ηα v
(α) of prototype flows v(α):
now the cost of v is homogenous (with degree 1) with respect to the coefficients ηα, where the basis may be
complete or even overcomplete, and we obtain the sum rule:
a =
∑
α
∂a
∂ηα
ηα (11)
for the coefficients ηα. The derivatives are given by
∂a
∂ηα
=
∑
l
∂a
∂vl
∂vl
∂ηα
= ∂a
∂v
· v(α). Again, there is an analogous
sum rule for scaled flux costs.
B.5 The optimum points of concave flux cost functions are polytope vertices
If all flows in a B-polytope are kinetically distinct, the optimal (enzyme-cost-minimising) flow must be a polytope
vertex. If several optimal flows exist, one of them must be a polytope vertex. We can see this as follows.
A concave flux cost function has a minimum point in a polytope vertex The enzymatic flux cost assumes
its minimum value on a B-polytope in one of the vertices. However, the same minimal value may also occur in
other, non-vertex points, but no lower values. We can see this as follows. Any polytope point v can be seen as
a convex combination
∑
α ηαv(α) of the vertices. If the enzymatic flux cost is concave on the B-polytope, the
cost a(v) must be equal or higher than the combined cost
∑
α ηαa(v(α)). This combined cost, in turn, must be
equal or higher than the lowest cost minαa(v(α)) among all vertices. Thus, if an interior point v assumes the
minimum cost value on the B-polytope, there will always be a vertex point with the same minimum value.
Concave flux cost functions have minimum points only on polytope vertices If the enzymatic flux cost
function is strictly concave on the B-polytope, its optima can only be vertex points. With strict concavity, the cost
of an interpolated flow v =
∑
α ηαv(α) (with ηα ∈]0, 1[,
∑
α ηα = 1) will be higher than the linearly combined
cost. Therefore, whenever a non-vertex point has a cost a, there will always be a vertex point with an even lower
cost.
B.6 Locally optimal flows
Definition B.2 Locally optimal flow. A flow is called locally optimal if ithas a lower flux cost than any other
flow in a small region around v within the B-polytope.
Proposition 5 (“Segaula criterion”) A polytope vertex v, with privileged metabolite profile m, represents an
optimal flow if if v is the only privileged flow of m (proof in section E.7).
Remark The proposition leads to an algorithm for constructing a locally optimal state (“Segaula algorithm”): (i)
Start from a given flow mode (e.g. obtained by running linear flux cost minimisation. (ii) Use ECM to compute
the privileged metabolite profile for this flow. (iii) Compute the apparent catalytic rates in the resulting state,
use them to define a linear flux cost minimisation problem, and solve it. (iv) Iterate steps (ii) and (iii) until
convergence. Note that the flows computed by linear flux cost minimisation are likely to be sparse (in models
11In taking the partial derivatives in Eq. (2), we consider flux variations that leave the polytope of stationary flows. However, this
is not a problem because the function a(v) is also defined for non-stationary flows.
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(a) Schematic explanation (b) Simulation results for branch point model
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Figure 8: During a flux reversal, some metabolite and enzyme levels change abruptly. (a) Schematic explanation.
Curves show enzymatic metabolite cost (y-axis) in log-metabolite space (x-axis), for one selected metabolite. The
dark blue curve represents the enzymatic cost from one reaction (whose direction is changing), and the light blue
curve shows the enzymatic cost in all other reactions. Their sum (red curve) determines the optimal metabolite
level (dot, x-coordinate) and enzyme cost (dot, y-coordinate). At a large forward flux (top), small metabolite
levels are thermodynamically impossible (shaded region). In the conditions shown further down, the flux changes
from positive to negative values. The cost of the flux-changing reaction is changing, while all other costs remain
almost constant (close to a flux reversal, this is a plausible assumption). At the point of flux reversal, the flux-
reverting reaction has zero flux and incurs no cost, and the optimal metabolite level is above the threshold value.
In the state with an (infinitesimally small) negative flux, the metabolite level must be below the threshold value.
This requires a jump in metabolite levels, and therefore enzyme levels and enzyme cost. (b) Simulation results
from the branch point model.
without flux constraints: EFMs) and that therefore, some metabolite levels may be ill-determined. This can be
fixed by using a regularisation term during ECM.
C Flux costs around points of flux reversal
For flows without predefined flux directions, i.e. flows in a single S-polytope, the flux cost function is concave.
However, what is the shape of this cost function in the entire flux space, if any feasible flow patterns are
allowed? By merging all feasible S-polytopes, we obtain a big (and typically non-convex) polytope of possible
flux distributions with any feasible flux signs. The flux cost function is concave within each of the S-polytopes.
However, what happens at the boundaries, where S-polytopes touch, and where fluxes change their directions?
Will the function remain concave, smooth, or at least continuous?
Flux reversals can be caused in two ways: by a change in external metabolite levels (which are model parameters),
or by changes in internal concentrations (which result from enzyme adaptations to any parameter changes in the
model). To study a flux cost function at the point of flux reversal, we revisit our branch point model from Figure
4. In this model (with three active reactions and a stationarity constraint for the branch point metabolite), there
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(a) Flux change (no flux reversal) (b) Flux reversal
Moment of reversal After reversalBefore reversalAfter changeBefore change
Figure 9: Metabolic changes during flux reversals. The drawings show enzymatic cost functions on the metabolite
polytope (schematic, model not shown). Physiological and thermodynamic constraints are shown by dashed lines,
enzymatic M-cost by colours from bright (low) to dark (high). Compare Figure 8 for a one-dimensional example.
(a) A flux change without flux reversal. The metabolite polytope remains unchanged, but the shape of the cost
function changes due to the changing desired flux, and the optimum point moves. (b) Flux reversal: a forward,
zero, or backward flux in one reaction leads to different M-polytopes. At the point of flux reversal (centre), the
optimum point is in the lower sub-polytope. Before the reversal (left), this optimum can already be realised. After
the reversal, at a slightly negative flux, it becomes inaccessible and another point, near the boundary of the new
M-polytope, becomes optimal. At larger negative fluxes, the optimum moves further away from the boundary
(not shown).
are 23 = 8 possible flow patterns, corresponding to the eight orthants in flux space. The plane of stationary fluxes
intersects six of these orthants, while any other two flow patterns can be discarded (these are patterns that would
lead to accumulation or depletion of the branch point metabolite). Thermodynamically, the flux directions are
determined by chemical potential differences: e.g. a positive flux v1 in Figure 4 requires that µX > µc. In the
example, we assume that µX > µY > µz , corresponding to a fixed choice of external metabolite levels. There
are two possible choices of µc that lead to stationary flows: either µc must be lower than µx and higher than
µy; then all fluxes run in forward direction; or it must be lower than µx and higher than µy; then the flux v2 is
reversed. With this choice of external chemical potentials, only two orthants in flux space remain feasible, and
the chemical potential µc determines which of them will be used (blue or red). Thus, given a choice of external
metabolite levels, the enzymatic flux cost is a function on the two coloured triangles. With a predefined objective
(e.g. flux v3), we obtain the B-polytope (thick black line in Figure 8). Within each part of the line (blue or red),
the cost function is concave. However, the flux cost function shows a jump at the polytope boundary. Figures
8 and 9 show what happens at the point of flux reversal. Between two S-polytopes, the flux cost function is
not continuous, except for some very unlikely cases (requiring fine-tuned model parameters). Also metabolite
levels, enzyme levels, and enyme cost are discontinuous, so the enzymatic flux cost has discontinuities between
S-polytopes. As the flow moves smoothly between the polytopes, the optimal metabolite and enzyme levels show
a a jump in their values rather than in their derivatives, i.e. a zeroth-order phase transition.
Generally, in order for fluxes to change their directions, the thermodynamic driving force and thus the metabolite
levels must change. In flux space, the metabolic flow will move to another segment and will cross the boundary
between two S-polytopes. At the same time, in metabolite space, the feasible metabolite polytope flips along
the boundary associated with the reversed reaction (see Figure 9) and the metabolite profile jumps to the new
polytope.
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D Variants of flux cost minimisation
D.1 Optimisation of enzyme activities at given desired fluxes and fixed enzyme con-
centrations
In our search for optimal flows in FCM assume that each flow is realised by its own optimal enzyme profile.
However, cells may sometimes not be able to adapt their enzyme levels, for example on very short time scales.
Anticipating fast, unpredictable metabolic changes, the cell may provide sufficient, constant enzyme levels for
various possible (or likely) situations, and then inhibit enzymes, whenever needed, by phosphorylation. In [8],
we showed that this problem – finding an optimal enzyme profile that will suffice to realise a finite set of flux
distributions – can be formulated as a convex optimality problem. Here we consider a slightly different scenario:
we assume that the cell has already chosen an enzyme profile, not matter how, and needs to realise a flow with a
maximal flux benefit (e.g. a maximal biomass production, or a maximal substance conversion), where the enzymes
may be inhibited. What is the optimal flow, the optimal metabolite profile, and the optimal profile of enzyme
activities? To model such a scenario, we consider a optimality problem in which the equality
vl = el rl (12)
is replaced by an inequality vl ≤ el rl (because the cell may inhibit some enzymes by phosphorylation), the enzyme
profile e is predefined, and we search for a flow (and a corresponding log-metabolite profile m) that maximises
a benefit value b′v · v. Instead of maximising the benefit numerically, we employ a trick: we compare flows v
providing a fixed nominal benefit b′ = b′v ·v (which allows us to consider optimality problems on the B-polytope);
then, for each flow, we assume that the benefit can be scaled by a factor σ, and we determine the maximal value
σopt(v) at which the enzyme constraint Eq. (12) can be satisfied. A high value of σopt means that the nominal
benefit b′ can be achieved at lower enzyme levels, or that a time-integrated benefit
∫
b′ dt can be reached in a
shorter period of time. To determine σopt for each flow v, we consider a variable σ to be maximised under the
constraint
∀l : σ vl ≤ el rl(m). (13)
Here the fluxes vl and enzyme levels el are given, rl(m) denotes the catalytic rates, and the log-metabolite levels
mi = ln ci are the variables to be optimised. For a flow v, the optimality problem reads
Maximise σ with respect to σ andm ∈ PM subject to ∀l : σ ≤
el rl(m)
vl
. (14)
The inequality constraints can be reformulated by defining σmax(m) = minl
el rl(m)
vl
, the maximal possible value
of σ that satisfies all the inequalities. We obtain
Maximise σmax(m) = min
l
el rl(m)
vl
with respect to m ∈ PM. (15)
Equivalently, we can minimise the inverse value:
Minimise
1
σmax(m)
= max
l
vl/el
rl(m)
with respect to m ∈ PM. (16)
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Since all terms on the right are convex in m, their maximum is convex, too12. Thus, for each flux v, the maximal
possible value of σ, called σopt(v), is obtained by solving a convex optimality problem for 1/σmax(m) on the
metabolite polytope. The function σopt(v) is monotonously decreasing13 in all fluxes vl. Given σ
opt(v), we can
define a◦(v) = 1/σopt, the cost/benefit ratio of flux v at fixed enzyme levels”. In contrast to our usual flux cost
function, this function need not be concave in flux space. For example, if two flux distributions vA and vB hit
the enzyme constraints Eq. (12) in different reactions, then by using a convex combination of the two flows, one
could relax both constraints and increase the flux at the given enzyme levels. As a rule of thumb, this means: if
enzyme levels are already given, then cells will rather use the available enzyme than using sparse flux distributions.
D.2 Models with non-enzymatic reactions
So far, we assumed that all reactions in our kinetic model are enzyme-catalysed. This makes each reaction flux
costly, but also directly controllable. In reality, there are non-enzymatic reactions, which changes the cost of
metabolic flows and may even render certain flows impossible. Non-enzymatic reactions include, for example, (i)
the damaging of molecules by free radicals; (ii) molecules leaving the cell by passive diffusion; (iii) the dilution
of substances in growing cells (which formally resemble a linear degradation reaction). In ECM, non-enzymatic
reactions will impose specific constraints on metabolite levels. For example, an irreversible reaction with mass-
action rate law and given flux defines a feasible plane within the M-polytope. (ii) A reversible reaction in
quasi-equilibrium will fix the ratio between its substrate and product levels. (iii) In models with dilution fluxes
λ ci, a given flux distribution v determines all dilution fluxes and, thereby, all metabolite levels! Such constraints
can restrict the M-polytope to lower-dimensional sub-polytopes or even to an empty set (i.e. the flow will not be
realisable). For flux cost minimisation, this means that some of the flows, even thermodynamically feasible ones,
may have to be omitted because they cannot be realised kinetically. Geometrically, parts of the flux polytope are
excluded for kinetic reasons, and the remaining set of lows may be non-convex. Instead, different flows in the
same S-polytope may correspond to different sections of an M-polytope; this means that the functions q(v,m),
obtained from different flows, reside on different sets in metabolite space and are not comparable anymore. In
addition, the flux cost function itself will change its shape, and our concavity proof does not hold anymore.
E Proofs
E.1 Proof of Lemma 2
To prove Lemma 2, we consider a kinetic flux cost a(v) = minm∈PS f(m;v) + g(m), where f(m;v) and g(m)
are bounded from below, and where f(m;v) is linear in v:
∀m ∈ PS : f(m; η vA + µvB) = η f(m;vA) + µ f(m;vB). (18)
To prove that a(v) is concave, we need to show that
a(η vA + µvB) ≥ η a(vA) + µa(vB) (19)
12This optimality problem resembles the standard ECM problem
Minimise qenz(m;v) =
∑
l
hl vl
rl(m)
with respect to m ∈ PM. (17)
Here, since each sum term is convex on PM, thsee sum (i.e., the enzymatic metabolite cost) is also convex.
13Here is a proof. Whenever a flux vl in (17) increases, the corresponding sum term increases as well. The maximum can only
increase, and σ will either decrease or remain the same. On the contrary, if a flux vl decreases, then σ must increase or remain the
same.
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for all η ∈ [0, 1] and µ = 1− η. We compute
a(η vA + µvB) = min
m∈PS
f(m; η vA + µvB) + g(m)
= min
m∈PS
[η f(m;vA) + η g(m) + µ f(m;vB) + µ g(m)]
≥ min
m∈PS
[η f(m;vA) + η g(m)] + min
m∈PS
[µ f(m;vB) + µ g(m)]
= η min
m∈PS
[f(m;vA) + g(m)] + µ min
m∈PS
[f(m;vB) + g(m)]
= η a(vA) + µa(vB). (20)
To obtain the inequality in the third line, we used the fact that by taking the minimum value of a sum of functions,
one cannot obtain a lower value than by summing the minimum values of the original functions.
E.2 Metabolite variations and their effect on enzymatic metabolite cost
When metabolite levels are changing (and the enzyme levels are fixed), this will usually change the reaction rates.
However, there are exceptions. To see which variations of the metabolite profile can affect the reaction rates, and
therefore the enzymatic cost at a given flux, we first introduce some terminology. We generally assume a given
flow pattern, and flux and metabolite profiles in the corresponding feasible polytopes.
Definition (Thermodynamically neutral metabolite variations) The thermodynamic force of reaction l, given
by Θl = −∆rGl/RT = −
∑
i nil si, is a linear function on the metabolite polytope. A metabolite variation δm
is called thermodynamically neutral if adding δm to any metabolite profile m leaves all thermodynamic forces Θl
unchanged. The set of thermodynamically neutral metabolite variations δm is called thermodynamically neutral
subspace. It is given by the nullspace of N⊤tot (where Ntot is the stoichiometric matrix referring to all – internal
and external – metabolites).
Definition (Mass-action neutral metabolite variations) In some rate laws, the reaction rate depends on
metabolite levels only through mass-action terms Sl =
∏
i c
mS
li
i (for substrates) and Pl =
∏
i c
mP
li
i (for products).
A metabolite variation δm is called mass-action neutral if adding δm to any metabolite profile m leaves all these
terms in a model unchanged. The set of mass-action neutral metabolite variations is called mass-action neutral
subspace. It is given by the nullspace of
(
MS
MP
)
.
Definition (Kinetically neutral metabolite variations) A metabolite variation δm is called kinetically neutral if
adding δm to any metabolite profile m leaves the rates of all reactions unchanged. The set of kinetically neutral
metabolite variations is called kinetically neutral subspace.
Definition (Cost-neutral metabolite variations) A metabolite variation δm is called cost-neutral if adding δm
to any metabolite profile m, at a fixed flow v, leaves the enzymatic metabolite cost qenz(m) unchanged. The
set of cost-neutral metabolite variations is called cost-neutral subspace.
All four criteria can be defined for entire models or single reactions. For example, a metabolite variation δm is
thermodynamically neutral for reaction l if it can be added to any metabolite profile m in the metabolite polytope
without changing the thermodynamic force of reaction l. The four criteria help us describe the nullspace of the
cost curvature matrix H for different types of rate laws:
1. “Reversibility-based” rate laws depend on metabolite concentrations solely through thermodynamic forces [8].
In models with suc rate laws, all thermodynamically neutral metabolite variations are both kinetically neutral
and cost-neutral. In such models, any nullvector of N⊤ will also be a nullvector of H.
2. “Saturation-based” rate laws depend on metabolite concentrations solely through the principal concentration
terms [8]. In models with such rate laws, all mass-action neutral metabolite variations are also kinetically
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neutral and cost-neutral. In such models, any nullvector of
(
MS
MP
)
will also be a nullvector of H.
3. Let S be the cost-neutral subspace of a model, i.e. the set of all cost-neutral metabolite variations. For
any difference vectors mA −mB, we can infer the implication mA −mB ∈ S ⇒ q
enz(mA) = q
enz(mB).
This means: any kinetically neutral variation δm is also cost-neutral and is therefore a nullvector of H,
i.e. H δm = 0. Thus, for reversibility-based rate laws, all thermodynamically neutral variations are cost-
neutral (and are therefore nullvectors of the cost curvature matrix), and for saturation-based rate laws, all
mass-action neutral variations are cost-neutral.
E.3 Proof of Lemma 1
The cost curvature matrix of the cost function qenz(m) depends on the desired flow v and on the metabolite
profile m. Lemma 1 states that the nullspace of this matrix does not depend on the specific choices of v and m,
but only on the flux polytope and the metabolite polytope from which they are taken; it is structurally determined
by rate laws, network structure, and flow pattern (specifying the active reactions and flux directions). To prove
this, we first note that all separable rate laws can be written as functions of the metabolite log-concentrations
mi = ln ci in the form
r(m) = kcat
1− e−RT (ln keq+n·m)∑
t at e
gt·m
, (21)
where the vector n contains the stoichiometric coefficients and the vectors gt follow from the rate law denominator
(see [8]). We first show two additional lemmas:
Lemma 3 The function
f(y) =
ea y
1− ey
(22)
with real-valued coefficient a is positively curved for all y < 0. To prove this lemma, we consider the second
derivative
∂2f
∂y2
=
a2 ea y
1− e y
+ ea y
(
e y
(1− e y)2
+
2 e2 y
(1− e y)3
)
+
2 a ea y
(1− e y)2
, (23)
which is positive for all y < 0.
Lemma 4 (Curvature of inverse rate law functions) The inverse of a separable rate law r(m), as a function
on the metabolite polytope, is positively curved in the subspace spanned by n and the vectors gt, and it has zero
curvature in any direction orthogonal to that subspace. Here is the proof. After omitting the constant prefactor
kcat, the inverse of the rate law Eq. (21) can be written as
1
r(m)
=
∑
t
eαt+gt·m
1− eβ+n′·m
, (24)
where the vector n′ is parallel to our original vector n and β + n′ ·m yields a negative number (because any
point m in the metabolite polytope must yield positive thermodynamic forces). If a metabolite variation δm
is orthogonal on n and on all gt, then 1/r(m + δm) = 1/r(m), and the function Eq. (24) has a vanishing
curvature in that direction. If a variation δm lies in the space spanned by n and all gt, then at least one of the
sum terms must depend on δm. Each sum term, as a function of m, is identical to Eq. (22) except for an affine
transformation, and must therefore be positively curved with respect to a scaling of δm.
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Proof of Lemma 1 The enzymatic metabolic cost function is given by q(m) =
∑
l
hl vl
rl(m)
, and its cost curvature
matrix is given by H(m) =
∑
l hl vl
∂2
∂m2
1
rl(m)
. Since ∂
2
∂m2
1
rl(m)
is convex (see [8]), all sum terms are positive
semidefinite, and the nullspace of H is given by the intersection of the nullspaces of all matrices ∂
2
∂m2
1
rl(m)
. To
show that the nullspace of H does not depend on the specific choices of m and v, we just need to show that the
nullspace of ∂
2
∂m2
1
rl(m)
, for single reactions l, does not depend on m. This can be proven by applying Lemma 4.
E.4 Proof of Proposition 3
Proposition 3 states that the enzymatic flux cost on the interpolation line between two conformal, kinetically
distinct flows is strictly concave. For the proof, we consider two flows vA and vB on the same P-polytope. By
solving the ECM problems for these two flows, we obtain optimal metabolite vectors mA and mB, as well as
the cost curvature matrices HA and HB in these points. Since our flows vA and vB are kinetically distinct by
assumption, the profiles mA and mB must be different (mA 6= mB) and cost-distinct (HA (mA −mB) 6= 0 and
HB (mA −mB) 6= 0). The latter condition holds because otherwise, each of the two, mA and mB, would be
optimal for both of the flows. In the following proof, we consider a convex combination vC of vA and vB (with
interpolation parameter 0 < η < 1) and its optimal metabolite vector mC.
1. We first show that the cost qenz(m;v) at a given flow v can be Taylor-expanded with respect to m in each
point of the metabolite polytope. Here is the proof: our cost function is a composition of exponentials and
rational functions (with no singularity points inside the metabolite polytope) and is therefore holomorphic
in every variable mi. By Hartogs’ theorem, it must also be holomorphic as a function of several variables.
Therefore, it can be approximated by a convergent power series in each interior point of the metabolite
polytope.
2. To show that the flux cost function a(v) is strictly concave, it is sufficient to show this for similar flows
vA ≈ vB. Since the cost function q
enz(m;v) is continuous in m and v, the optimal metabolite profiles
mA, mB, and mC will be similar, too. To simplify the notation, we write q
enz
A (m) = q
enz(m;vA) and
qenzB (m) = q
enz(m;vB). Now we approximate the cost by a quadratic expansion (see point 1)
qenzA (m) = q
enz
A (mA) +
1
2
(m −mA)
⊤HA(m−mA)
qenzB (m) = q
enz
B (mB) +
1
2
(m−mB)
⊤HB(m−mB). (25)
For each given metabolite profile m, the two functions are additive between vA and vB. Therefore, the
enzymatic metabolite cost for the interpolated flow vC reads
qenzC (m) = [1− η] q
enz
A (m) + η q
enz
B (m)
= [1− η] [qenzA (mA) +
1
2
(m−mA)
⊤HA(m −mA)] + η [q
enz
B (mB) +
1
2
(m−mB)
⊤HB(m −mB)]
= [1− η]qenzA (mA) + η q
enz
B (mB)︸ ︷︷ ︸
qinterp
+
1
2
[[1− η](m −mA)
⊤HA(m −mA) + η (m −mB)
⊤HB(m−mB)︸ ︷︷ ︸
∆q
] (26)
The first term describes the linearly interpolated costs of vA and vB. The second term, called compromise
cost ∆q, is non-negative. This already shows that the flux cost function must be concave. In the next step,
we show that ∆q is actually positive, i.e. the flux cost function is strictly concave.
3. To find the optimal metabolite profile mC for our combined flow vC, we minimise th ecompromise cost ∆q
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with respect to m. First, we rewrite ∆q as
∆q = [1− η]
[
m⊤HAm− 2m
⊤HAmA +mA)
⊤HAmA
]
+η
[
m⊤HBm− 2m
⊤HBmB +m
⊤
BHBmB
]
. (27)
Omitting some constant terms, we obtain
∆q′ = [1− η]
[
m⊤HAm− 2m
⊤HAmA
]
+ η
[
m⊤HBm− 2m
⊤HBmB
]
= m⊤ [[1− η]HA + ηHB]︸ ︷︷ ︸
HC
m− 2m⊤ [[1− η]HAmA + ηHBmB] . (28)
Minimising ∆q′ with respect to m, we obtain the optimal metabolite profile mC:
mC = H
−1
C [[1− η]HAmA + ηHBmB] . (29)
4. For later use, we now show that mC 6= mA and mC 6= mB (and still assume that 0 < η < 1). We prove
mC 6= mA by contradiction: we first assume that mC = mA, and obtain
mA = mC = H
−1
C [[1− η]HAmA + ηHBmB]
⇒ HC mA = [1− η]HAmA + ηHBmB
⇒ [[1− η]HA + ηHB]mA = [1− η]HAmA + ηHBmB
⇒ ηHB mA = ηHBmB
⇒ HB(mA −mB) = 0. (30)
This would imply that either mA = mB, or that mA −mB is a nullvector of HB and therefore cost-neutral.
This contradicts our initial assumptions. The proof for mB is analogous.
5. We now start again from the expression for ∆q in Eq. (26), insert the optimal metabolite profile mC, and
obtain
∆q = [1− η](mC −mA)
⊤HA(mC −mA) + η(mC −mB)
⊤HB(mC −mB). (31)
To complete our proof, we need to show that this expression is strictly positive. It cannot be negative, because
the matrix products are symmetric and the prefactors [1− η] and η are non-negative. Thus, we only need to
show that it cannot vanish. We already saw that (mC−mA) and (mC−mB) cannot vanish. Thus, in order
for ∆q to vanish, (mC −mA) would have to be in the nullspace of HA, and mC −mB would have to be
in the nullspace of HB. According to Lemma 1, the two nullspaces are structurally determined and therefore
identical. Thus, for ∆q to vanish, the difference mA −mB must be in this nullspace, which contradicts our
assumptions.
E.5 The enzymatic metabolite cost obtained from common modular rate laws is
strictly convex
In models with common modular (CM) rate laws, the enzymatic metabolite cost function has a strictly positive cost
curvature matrix and is therefore strictly convex. In the following proof, found by Joost Hulshof (VU Amsterdam),
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this is first shown for one reaction and then for an entire network. We consider an CM rate law
v = E
k+
∏
i∈sub(
ci
ki
)m
sub
i (1− e−Θ(x))∏
i∈sub(1 +
ci
ki
)m
sub
i +
∏
i∈prod(1 +
ci
ki
)m
prod
i − 1
, (32)
where msubi and m
prod
i denote the molecularities (i.e. positive stoichiometric coefficients) of substrates and
products. We focus on one reaction and consider all internal metabolites that appear in the rate law. The enzyme
cost, as a function of the log-concentrations of these metabolite only, reads
y = he v
∏
i∈sub(1 +
ci
ki
)m
sub
i +
∏
i∈prod(1 +
ci
ki
)m
prod
i − 1
k+
∏
i∈sub(
ci
ki
)m
sub
i (1− e−Θ(x))
. (33)
The numerator is a polynomial of the form
1 +
∏
i
(
ci
ki
)|ni| + ..., (34)
where all following terms are powers of metabolite concentrations with positive prefactors. Following the proof
by Joost Hulshof, we now expand the denominator. The thermodynamic term alone would yield 1
1−e−Θ(x) = 1+
e−Θ(x)+e−2Θ(x)+... (for positive driving forcesΘ, this series converges). Multiplying this by k+
∏
i∈sub(
ci
ki
)−m
sub
i ,
we obtain
k+ (
∏
i∈sub
(
ci
ki
)−m
sub
i )(1 + e−Θ(x) + e−2Θ(x) + ...)
= k+
∏
i∈sub
(
ci
ki
)−m
sub
i + k+
∏
i∈sub
(
ci
ki
)−m
sub
i e−Θ(x) + ...
= k+
∏
i∈sub
(
ci
ki
)−m
sub
i + k−
∏
i∈prod
(
ci
ki
)m
prod
i + ... (35)
where all remaining terms are powers of metabolite concentrations with positive cofactors. Multiplying this with
the numerator and writing it in terms of log-concentrations, we obtain a series of terms, each describing a function
that is positively curved in all log-concentrations. Thus, the cost curvature matrix for this reaction is positive
definite with respect to the log-concentrations of all metabolites participating in the reaction. If we consider a
kinetic model with CM rate laws, the cost curvature matrix will be a sum of cost curvature matrixs for the single
reactions. It will therefore be positive definite in all metabolites that appear in the enzymatic rate laws.
E.6 Gradient of the enzyme-based flux cost Eq. (7) and identity between flux and
enzyme point cost
To compute the gradient ∂a/∂v of an enzyme-based flux cost function, we consider a reference flow vref with
optimal metabolite profile mref = mopt(vref). A small variation δv will change the optimal metabolite profile by
δm. The new enzyme-based flux cost can be approximated to first order:
a(vref + δv) = qenz(mref + δm;vref + δv)
≈ qenz(mref ;vref) +
∂qenz(mref ;v)
∂v
|v=vref δv +
∂qenz(m;vref)
∂m︸ ︷︷ ︸
0
δm. (36)
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The prefactor of δv in this formula yields the flux cost gradient ∂a/∂v:
∂a(v)
∂vl
=
∂qenz(mopt(v);v)
∂vl
=
∂
∂vl
hel vl
rl(mopt(v))
=
hel
rl(mopt(v))
. (37)
where mopt(v) is the optimal metabolite profile for v. We can therefore linearly expand the flux cost function as
a(v + δv) ≈ qenz(mopt(v);v + δv) = a(v) + qenz(mopt(v); δv) (38)
and obtain the flux point cost
∂a(v)
∂vl
vl =
hel
rl
vl = hel el =
∂h
∂el
el. (39)
The flux point cost is therefore identical to the enzyme point cost.
E.7 Criterion for locally optimal flows (proposition 5)
Let v(1) a polytope vertex to be checked from being locally optimal. Let v(2),v(3), .., be all other polytope
vertices. For v(1) to be locally optimal, any infinitesimal movement δv towards towards the interior of the B-
polytope must increase the cost, i.e., a(v(1) + δv) > a(v(1)). According to SI section E.6, we can write the left
side as a(v(1)) + q(m; δv) and obtain the condition q(m; δv) > 0. Any vector δv can be written as a convex
combination ε
∑
k 6=1 ηk(v
(k) − v(1)) with an infinitesimal prefactor ε, and since q is linear with respect to v, we
obtain the condition ε
∑
k 6=1 ηk q(m;v
(k) − v(1)) > 0. To show that this holds true, we just need show that
q(m;v(k)−v(1)) > 0 for any other vertex v(k). Again, by linearity, this is equivalent to q(m;v(k)) > q(m;v(1)),
which is true by assumption (v(1) being the only privileged flow of m).
E.8 Linear approximations of the enzyme-based flux cost function
The linearised flux cost function Eq. (8) is obtained by a linear expansion
a(v) ≈ a(vref) +
∑
l
∂a
∂vl
|vref (vl − v
ref
l ) = a(v
ref) +
∑
l
∂a
∂vl
|vref vl −
∑
l
∂a
∂vl
|vref v
ref
l
︸ ︷︷ ︸
a(vref )
=
∑
l
∂a
∂vl
|vref vl. (40)
The sum rule Eq. (2) was used to simplify the sum expression. This proof also holds for effective metabolite cost
functions q(m) + qenz(m;v) and the resulting kinetic flux cost functions. The gradient ∂q(m)
∂vl
of the metabolite
cost vanishes, so the formula for ∂a/∂vl remains unchanged. However, the optimal m vector, at which the
gradient is evaluated, will be different.
E.9 Nonlinear approximation of enzyme-based flux cost, computed from prototype
flows
Enzymatic flux cost functions can be linearly or nonlinearly approximated. For a linear approximation, we choose
a reference flow vref (in which all reactions must be active) and determine its privileged metabolite levels c
ref
i .
The enzyme-specific reaction rates in this state are called rrefl = rl(c
ref). For our reference flow vref , this yields
the flux-specific enzyme costs
(
ql
vl
)
ref
= hel
erefl
vrefl
=
hel
rrefl
. (41)
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To approximate the flux cost function around vref , we treat these flux-specific costs as constant numbers and set
a(v) =
∑
l
ql
vl
vl ≈
∑
l
(
ql
vl
)
ref
vl =
∑
l
hel
rrefl
vl, (42)
where we used the sum rule Eq. (2) as well as Eq. (40). We obtain a linear flux cost function with cost weights
defined by the specific rates rl obtained from our reference flow. For a nonlinear approximation, we apply the
same procedure, but with several prototype flows v(α) instead of a single reference flow. For each prototype flow
v(α) we determine the optimal metabolite profile and the resulting specific rates r
(α)
l . To obtain a flux cost a(v),
we approximate the flow v by a convex combination v ≈
∑
α ηα v
(α) of the prototype flows. Then we use the
weights ηα from this expansion to define a weighted mean
14 of the inverse specific rates: 1/r′l =
∑
α ηα/r
(α)
l and
use this value as an estimate of 1/r′l for our flow v. Now, we apply the summation theorem for flux point costs
a(v) =
∑
l
∂a(v)
∂vl
vl =
∑
l
hel
rl(v)
vl. (43)
Replacing the value rl(v) by our estimate r
′
l(v), we obtain the nonlinear approximation
15
a(v) ≈
∑
l
hel
r′l
vl. (44)
In brief, the trick is to approximate the inverse specific rate rl(v)
−1 by interpolating the inverse specific rates
rl(v
(α))−1 of the prototype fluxes. The calculation works even if our prototype flows contain vanishing reaction
fluxes, provided that the specific rates rl(v
(α)) do not vanish. If a reaction is exactly in thermodynamic equilibrium,
or if it is completely inhibited, then rl(v
(α)) will vanish, and this reaction cannot be active, even with an arbitrarily
high enzyme investment. Flows that contain such reactions cannot be used as prototype flows.
E.10 The cell growth rate as a convex function on the B-polytope
Proposition 6 We assume that the enzyme cost a(v), at a given biomass production can be converted into a
cell growth rate λ by a decreasing, convex cost-growth function λ(a). The resulting growth rate λ(a(v)) is a
convex function on the B-polytope. If the enzymatic flux cost a(v) is strictly concave on the B-polytope, the
growth rate λ(a(v)) is strictly convex on the B-polytope.
Proof Consider a strictly concave enzymatic flux cost a(v) on the B-polytope and a monotonically decreasing,
convex cost-growth function λ(a). We consider two flows vA and vB. Since a(v) is strictly concave, we obtain
a(η vA + [1− η]vB) > η a(vA) + [1− η] a(vB), (45)
where 0 < η < 1. Since λ(a) is monotonically decreasing, we obtain
λ(a(η vA + [1− η]vB)) < λ(η a(vA) + [1− η] a(vB)) (46)
and since λ(a) is convex,
λ(a(η vA + [1− η]vB)) < η λ(a(vA)) + [1− η]λ(a(vB)). (47)
14It may sometimes be preferable to approximate v by a non-convex combination with positive weights ηα that do not sum to 1.
In this case, the weighted mean 1/r′l is computed using the scaled weights η
′
α = ηα/(
∑
β ηβ).
15The approximated flux cost function Eq. (44) is quadratic. To see this, we collect the prototype vectors vA,vB,vC .. in a matrix
and and set v = (vA vB vC ..)η. We can determine η = (vA vB vC ..)
+
v by using the pseudoinverse of this matrix. Therefore,
the vector η is linear in v, and inserting η into the expansion a ≈
∑
l
hl
r∗l
vl =
∑
lα
ηα
rl
hl vl yields a quadratic function in v.
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Thus λ(a(v)) is strictly convex. Likewise, if a(v) is non-strictly concave, then λ(a(v)) will be non-strictly convex
(same proof, with inequality ≥ instead of >).
Typical cost-growth functions (as proposed in the literature [12, 10] are hyperbolically shaped and decreasing,
and therefore convex. To derive such a growth formula λ(rBM), we consider the biomass concentration cBM
(given, e.g. in carbon moles / cell volume) and a biomass production rate vBM . For a simple growth formula,
we assume that the metabolic enzymes in the cell have a fixed total concentration cME. In this case, the cell
growth rate is given by λ = vBM/cBM =
vBM
cME
cME
cBM
= rBM ρME with the enzyme-specific biomass production rate
rBM = 1/a (where the enzymatic cost a refers to fluxes with unit biomass production) and the enzyme fraction
(metabolic enzyme concentration / biomass concentration) ρME). The growth rate is proportional to rBM, and
therefore inversely proportional to the enzymatic flux cost a. To obtain a second, more realistic growth formulae,
we consider the fact that the enzyme fraction in the biomass is growth-rate dependent. This can be explained
by a compromise between investments in metabolic enzymes and ribosomes. Following the resource allocation
model of Scott et al. [12], one obtains a saturable (Michaelis-Menten-like) formula of the form λ = λmax rBM
rBM+k
with a maximal growth rate λmax and a constant Monod constant k. The resulting cost-growth function has the
hyperbolic form λ(a) = λmax k
′
k′+a (see [10]).
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